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The vertebrate inner ear is a structurally complex sensory organ responsible for 
detecting sound and maintaining balance. These functions are mediated by 
specialized sensory epithelia comprised of a mosaic of mechano-transducing hair 
cells and supporting cells. The sensory hair cells are innervated by neurons of the 
cochleo-vestibular ganglion (CVG, the VIIIth cranial nerve). Both neuronal and 
sensory lineages are thought to be specified early in the neural-sensory competent 
domain (NSD) of the ear rudiment. First, neuroblasts delaminate from the NSD to 
form neurons of the CVG. Then, cells remaining in the NSD adopt a sensory fate and 
develop into various sensory organs. The molecular mechanisms that specify 
neuronal and sensory cell fates are unclear. The aim of this dissertation is to provide a 
better understanding by examining the roles of the HMG (high mobility group)-box 
containing transcription factors Sox2 and Sox3 in developing chicken inner ears using 
gain and loss-of-function approaches. Over-expression of Sox2 in ovo readily induces 
Neurogenin 1 (Ngn1) expression, an important gene required for the neurogenic fate. 
  
Nevertheless, neurogenesis fails to proceed based on the lack of Neurod1 up-
regulation and consequently the size of the CVG is reduced. In contrast, over-
expression of Ngn1 is capable of up-regulating Neurod1 and causes increased 
neuroblast formation, as well as Sox2 down-regulation. Similar increases in 
neurogenesis are obtained with over-expression of Neurod1. I provide evidence that 
Ngn1 and Neurod1 inhibit Sox2 transcription via the E-box of the nasal-otic placode 
specific enhancer 1 (NOP-1) within the Sox2 promoter. On the other hand, loss of 
Sox2 function paradigms did not result in loss of Ngn1 expression, suggesting that 
other factors may be required to induce Ngn1 normally. Furthermore, while Sox3 has 
been proposed to be up-stream of Sox2, it does not induce Ngn1 in a similar manner 
as Sox2. Taken together, my results suggest that Sox2 and likely other factors are 
involved in initiating neurogenesis by up-regulating Ngn1. The up-regulated Ngn1, in 
turn, down-regulates Sox2 expression and up-regulates Neurod1 to mediate 
progression of neurogenesis. Finally, I show that Sox2 and the Notch signaling 
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Chapter 1: Introduction 
The vertebrate inner ear develops in a precise spatio-temporal pattern. 
Specialized sensory epithelia within the inner ear, which are comprised of hair cells 
and their associated supporting cells, are responsible for mediating balance and 
hearing. These sensory patches are innervated by neurons of the cochlea-vestibular 
ganglion. Both sensory and neuronal lineages are thought to arise from a common 
neural-sensory competent domain (NSD) in the ear rudiment. Much work and efforts 
are focused on unraveling how sensory organs develop and how cells in the sensory 
and neuronal lineages adopt their fates. Despite these efforts a clear understanding of 
the molecular mechanisms is still lacking. The aim of this dissertation is to seek a 
better understanding of the molecular mechanisms involved in the regulation of 
neuronal and sensory cell fate choices. To this end, I have conducted gain and loss-of-
function studies in chicken inner ears in ovo using an electroporation method that I 
have developed. This study focuses on the functions of Sox2 and Sox3, because the 
roles of these genes in inner ear development are largely unknown. Yet, mutations in 
the SOX2 gene lead to sensorineural hearing loss in humans and mice (Hagstrom et 
al., 2005; Kiernan et al., 2005). 
 
Development of the inner ear  
The development of the inner ear depends on many molecular processes 
including inductive signals emanating from the hindbrain, mesoderm, and ectoderm. 
This organ originates from a thickening of the ectodermal tissue adjacent to the 





cup and quickly closes to form the fluid-filled otocyst, which gives rise to the entire 
membranous labyrinth of the inner ear and the neurons that innervate it. Genetic 
fate-mapping data indicate that neuronal and sensory lineages arise from the NSD 
located in the antero-ventral region of the otic cup or otocyst (Raft et al., 2007). 
First, neuroblasts delaminate from the NSD to form the neurons of the cochleo-
vestibular ganglion (CVG, the VIIIth cranial nerve), which eventually split into 
auditory and vestibular ganglia. These neurons innervate the sensory hair cells of 
the inner ear and nuclei in the brainstem. The cells that remain in the NSD are 
thought to give rise to various sensory patches consisting of the mechano-
transducing sensory hair cells and their associated supporting cells.  
Chicken inner ears have seven vestibular sensory organs for maintaining 
balance and one auditory organ for detecting sound. The vestibular organs consist of 
the three cristae, utricular macula, saccular macula, macula neglecta, and macula 
lagena. The auditory organ is the basilar papilla. The total number of sensory organs 
in chicken differs from mammalian inner ears, as mammals do not have a lagena. 
Furthermore, the auditory organ in mammals is the organ of Corti, which is more 
complex in structure than the basilar papilla. Despite these differences, the 
molecular pathways for patterning and morphogenesis between avian and 
mammalian inner ears are quite similar.  
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Figure 1.1. Timetable of chicken inner ear development. Stages are based on 
Hamburger & Hamilton 1951. Abbreviations: E, embryonic day; NSD, neural-
sensory competent domain; CVG, cochleo-vestibular ganglion. Figure modified from 









A common NSD gives rise to the neuronal and sensory lineages  
Several studies suggest that neuronal and sensory fates are related by lineage 
(Fig.1.2). For instance, fate-mapping studies using replication incompetent 
retroviruses in chicken inner ears show that sensory cells in the utricular macula and 
the CVG are clonally related (Satoh and Fekete, 2005). In addition, genetic fate-
mapping studies of Neurogenin1 (Ngn1)-positive cells in the NSD of the mouse 
shows that these cells give rise to neuroblasts of the CVG as well as to sensory cells 
of the utricular and saccular maculae (Raft et al., 2007). Ngn1 encodes a pro-neural 
basic-Helix-Loop-Helix (bHLH) transcription factor associated with the neuronal 
fate and is expressed in a subset of cells within the NSD. In the absence of Ngn1 
CVG formation is severely affected (Liu et al., 2000; Ma et al., 2000; Matei et al., 
2005). Besides Ngn1, the molecular mechanisms that lead up to the induction of 
Ngn1 and subsequent neuroblast differentiation are unclear. 
 
The NSD is marked by the expression domains of several genes in the inner ear 
The NSD of the inner ear lies anterior-ventral-medially and is specified and 
marked by a temporal cascade of molecules, which are proposed to mediate 
neurogenesis: Fgf10>Ngn1/Delta1/Hes5>Neurod1/NeuroM (Alsina et al., 2004). 
Fgf10 belongs to the fibroblast growth factor family. Forced expression of Fgf10 in 
the chicken inner ear leads to an increase in Neurod1 (also known as NeuroD1) and 
NeuroM-positive neuroblasts, and inhibition of Fgf receptor signaling leads to a loss 
of Ngn1, Neurod1, Delta1, and Hes5 expression (Alsina et al., 2004). Therefore, Fgf 





2004). Delta1 is a ligand for the Notch receptor involved in specification of the 
neuronal fate through Notch-signaling mediated lateral inhibition, and Hes5 belongs 
to the bHLH family of transcription factors that is a negative regulator of pro-neural 
bHLH transcription factors Ngn1, Neurod1, and NeuroM (Cau et al., 2000; Daudet 
et al., 2007). Hes5 is known to be expressed in cells destined to become sensory and 
shown to be involved in the formation of hair cells (Zine et al., 2001). Expression of 
Delta1, Hes5, Ngn1, Neurod1, and NeuroM all have a salt-and-pepper pattern in the 
NSD, suggesting that cells within the NSD are selectively expressing these genes 
destined to become neuronal or sensory cells (Alsina et al., 2004). Ngn1 is required 
for the neuronal fate and it is transiently expressed in neuroblasts (Ma et al., 2000; 
Matei et al., 2005; Raft et al., 2007). One of Ngn1’s functions is thought to be up-
regulation of Neurod1, which is required to mediate neuroblast differentiation (Liu 
et al., 2000; Ma et al., 1996).  
 
Sox2 and Sox3 are expressed in the NSD  
Sry-related HMG-box 2 and 3 transcription factors (Sox2 and Sox3) are 
expressed in the NSD. Their expression patterns overlap with that of Lunatic fringe 
(Lfng) and Ngn1. Lfng encodes an extra-cellular protein, which modulates Notch 
signaling. Its expression domain in the otic cup encompasses Ngn1, Sox2, and Sox3 
positive regions. However, Lfng null mice mutants have no apparent inner ear 
phenotype (Zhang et al., 2000). For the purpose of this study Lfng serves as a 





The expression patterns of Sox2 and Sox3 are dynamic within the neuronal 
and sensory lineages (Fig.1.2). While Sox2 and Sox3 are expressed in the NSD, both 
gene activities are down-regulated in the delaminated Neurod1-positive neuroblasts 
and only the expression of Sox2 and not Sox3 persists in the sensory lineage (this 
study and (Neves et al., 2007)). By the time various sensory patches start to 
differentiate, Sox2 is further down-regulated in differentiating hair cells but its 
expression remains in supporting cells (Neves et al., 2007). These expression 
patterns suggest that Sox2 and Sox3 may be required to be down-regulated upon 
neuronal differentiation and Sox2 expression in the sensory patches undergoes 
further down-regulation during hair cell differentiation. This is the hypothesis being 
addressed in this dissertation. 
 















          Figure 1.2 
 
Figure 1.2. A common neural-sensory competent domain gives rise to the 
neuronal and the sensory lineages. Sox2 and Sox3 are both initially expressed in 
the NSD. They are soon down-regulated in delaminating neuroblasts (this study and 
(Neves et al., 2007)), whereas the expression of Sox2 persists in the sensory lineage. 
These expression patterns suggest that there is a requirement for Sox2 and Sox3 to 
be down-regulated for neuronal differentiation and that there is a requirement for 
Sox2 down-regulation for hair cell differentiation. Ngn1 and Neurod1 are both 
expressed in neuronal progenitors and required for the formation of the CVG. Ngn1 
is transiently expressed in delaminated neuroblasts, whereas expression of Neurod1 






The requirement of Sox2 and Sox3 in the central nervous system and inner ear 
development 
Sox1, Sox2, and Sox3 belong to group B1 of the evolutionarily conserved 
family of Sry-related High-Mobility-Group (HMG) box genes, which encode 
transcription factors (Lefebvre et al., 2007). The HMG domain of these transcription 
factors mediates nuclear translocation and partners with other factors for binding to 
DNA (Kamachi et al., 2000; Lefebvre et al., 2007; Wilson and Koopman, 2002). 
The C-termini of Sox proteins are responsible for transcriptional activation or 
repression (Kamachi et al., 2000; Lefebvre et al., 2007; Wilson and Koopman, 
2002). Sox proteins require the interaction of a binding co-partner that interacts with 
the HMG domain in a cell-context dependent manner (Kamachi et al., 2000; Wilson 
and Koopman, 2002). However, the C-terminal activation or repression domains are 
not cell-specific and not dependent on co-partners, but they do require stable DNA 
binding to the target through the HMG domain and the co-partner (Kamachi et al., 
2000; Wilson and Koopman, 2002). Therefore, the specificity of the mode of action 
of Sox proteins is cell-context dependent, relying on co-partners (Kamachi et al., 
2000; Wilson and Koopman, 2002).  
There are about 20 Sox genes expressed in vertebrates and the overall role of 
these genes is to maintain stemness, i.e. a self-renewing progenitor cell state, and to 
regulate cell fate and differentiation (Lefebvre et al., 2007). Some regulatory 
elements of Sox2 have been identified within the Sox2 promoter, including the 
conserved nasal-otic placode-specific enhancers 1 and 2 (NOP-1 and NOP-2), 





et al., 2003). Sox2 and Sox3 appear to function as transcriptional activators in the 
central nervous system and Sox2 is involved in the development of several other 
organs, such as the lung, tongue, and eye (Bani-Yaghoub et al., 2006; Bylund et al., 
2003; Gontan et al., 2008; Okubo et al., 2006; Taranova et al., 2006).  In the chicken 
neural tube, Sox2 and Sox3 block neurogenesis by maintaining a progenitor status, 
whereas Ngn2 counteracts Sox2 and Sox3 activity presumably to promote 
neurogenesis through a yet to be determined molecular mechanism (Bylund et al., 
2003). In blastocysts, Sox2 mediates self-renewal and pluripotency in embryonic 
stem cells (Boyer et al., 2005; Chew et al., 2005; Loh et al., 2006). In the 
developing lung, Sox2 expression has to be down-regulated for branching 
morphogenesis and is required for epithelial cell differentiation (Gontan et al., 
2008). In the developing tongue, Sox2 is required for differentiation of taste buds 
(Okubo et al., 2006). Therefore, Sox2’s role of initially maintaining a proliferative 
progenitor pool, and its subsequent requirement for its expression to be down-
regulated to mediate cellular differentiation seems to be a common theme 
underlying Sox2 function throughout development, including the inner ear. 
Nevertheless, the mechanisms that regulate the levels of Sox2 activities required for 
these various cellular processes are not clear. 
In humans, mutations in the SOX2 gene cause sensorineural hearing loss 
(Hagstrom et al., 2005). Furthermore, analyses of two mouse mutants, light coat and 
circling (lcc) and yellow submarine (ysb), show that Sox2 is required for sensory 
organ development (Kiernan et al., 2005). The lcc mutant has no Sox2 expression, 





develop sensory organs and ysb mutants have only some sensory patches. These 
findings indicate that Sox2 function is essential for the development of the sensory 
organs and Sox2 is commonly thought of as a pro-sensory gene. The role of Sox2 or 
Sox3 in the neurogenic fate of the inner ear is unclear. Given the dynamic 
expression patterns of Sox2 and Sox3 during early stages of inner ear development, 
these genes are good candidates for mediating neuronal as well as sensory fates. 
This dissertation addresses the roles of Sox2 and Sox3 in this context, in particular 
with regard to the neuronal fate (Chapter 2). Furthermore, because Sox1 is not 
expressed in the NSD and it is only expressed in the anterior and lateral cristae 
starting at E3.5 (not shown), experiments with Sox1 were not pursued in this study. 
 
The neuronal fate in the inner ear is in part regulated through Notch signaling 
The Notch signaling pathway plays important roles during embryogenesis. It 
generates cell type diversity through lateral inhibition, cell lineage decisions, and 
cell boundary formation (Weir et al., 2000). The process of lateral inhibition is in 
part responsible for regulating neurogenesis (Fig. 1.3). The working model for 
Notch signaling in vertebrates is similar to Notch signaling during the acquisition of 
the neuronal fate in Drosophila (Bertrand et al., 2002). Initially, Notch receptors 
such as Notch1 are expressed equivalently in neuroepithelial progenitors. As levels 
of pro-neural genes such as Ngn1 increase in progenitors destined to become 
neuronal, levels of the Notch ligand such as Delta1 also increase in these cells, and 
this inhibits neighboring cells from adopting the same neuronal fate.  Ligand-





receptor by the enzyme γ-secretase and the release of the intracellular domain of 
Notch (Notch-ICD). The Notch-ICD in turn translocates to the nucleus to activate a 
set of genes including Hes and Hey, which inhibit the neuronal fate. For example, 
Hes5 has been shown to negatively regulate pro-neural bHLH genes including Ngn1 
during mouse olfactory placode neurogenesis (Cau et al., 2000). Another aspect of 
Notch signaling is lateral induction (see below). As opposed to lateral inhibition, 
this is a process of positive feedback and is involved in establishing the pro-sensory 
domain and the hair cell fate in the inner ear (Brooker et al., 2006; Daudet and 
Lewis, 2005; Hartman et al., 2010; Kiernan et al., 2001; Kiernan et al., 2005; 
Lanford et al., 1999; Pan et al., 2010; Tsai et al., 2001).  
 In the chicken inner ear, Notch1 receptors and their ligands, Serrate1 (Ser1, 
also known as Jag1 in the mouse) and Delta1 are specifically expressed in the NSD 
(Adam et al., 1998). When Notch signaling in the chicken otic cup is blocked with 
DAPT, a chemical compound that inhibits γ-secretase activity, neurogenesis is 
increased because lateral inhibition is alleviated and genes that are normally 
activated by Notch signaling such as Hes5.1 (a chicken homolog of mammalian 
Hes5) are down-regulated (Daudet et al., 2007).  
In addition, studies of mouse cochlear explant cultures suggest that Notch 
signaling functions up-stream of Sox2. Over-expression of Notch-ICD leads to up-
regulation of Sox2, and when Notch signaling is blocked with DAPT, Sox2 
expression is down-regulated (Dabdoub et al., 2008). In the chicken otic cup, it has 
been proposed that Sox2 expression is induced through Ser1-mediated Notch 





signaling could also be down-stream of Sox2 since a direct Sox2 binding site in the 
promoter of Notch1 has been identified (Taranova et al., 2006). Therefore, Sox2 and 
the Notch signaling pathway may function in close association to mediate neuronal 
and sensory cell fate choices in the inner ear. This dissertation addresses the 
potential relationships between Sox2 and the Notch signaling pathway within this 
context (Chapter 3). 
 







Figure 1.3.  Notch signaling mediates cell fate choices. Cells that express Delta or 
Serrate ligands signal to neighboring cells not to adopt the same fate via the Notch 
receptor; a process known as lateral inhibition. Upon ligand-binding, the intracellular 





activate genes such as Hes and Hey with the help of other binding proteins and co-
factors. Figure modified from http://www.angiolab.de/research/fig1_Fischer.jpg  
 
Notch signaling creates cell diversity through lateral induction and inhibition  
 The mammalian sensory epithelium of the cochlea, the organ of Corti, 
consists of one row of inner hair cells and three rows of outer hair cells. This 
patterning is absent in the chicken basilar papilla. Nevertheless, tall and short hair 
cells in the basilar papilla are analogous to inner and outer hair cells in mammals, 
respectively. Hair cells and their associated supporting cells are generated in a mosaic 
through lateral inhibition. However, the pro-sensory domain from which hair cells 
and supporting cells arise is established through lateral induction. Hair cells in the 
mouse and chicken cochlea differentiate several days after the initiation of 
neurogenesis. After neuroblasts delaminate from the NSD, cells remaining in this 
domain presumably adopt the sensory fate. It has been proposed that from this 
equipotential patch of sensory tissue, the hair cell fate is the default fate (Lanford et 
al., 1999). In this proposed model, initially all cells within the equipotential patch 
express Notch, then these cells developmentally progress and sensory progenitors 
express Ser/Jag ligands with decreased expression of Notch, whereas the surrounding 
cells have a high level of Notch expression (Daudet and Lewis, 2005; Lanford et al., 
1999). Then, nascent hair cells emerge expressing Delta1 and Ser2/Jag2 ligands with 
surrounding cells expressing Ser1/Jag1 (Daudet and Lewis, 2005; Lanford et al., 
1999; Tsai et al., 2001). The current dogma is that Ser1/Jag1-mediated Notch 





signaling is responsible for generating the mosaic of hair and supporting cell types via 
lateral inhibition (Brooker et al., 2006; Daudet and Lewis, 2005; Hartman et al., 2010; 
Kiernan et al., 2001; Kiernan et al., 2005; Lanford et al., 1999; Pan et al., 2010; Tsai 
et al., 2001).  
 Several mouse models and studies in the chick support the above models of 
lateral induction and inhibition. Ser1/Jag1 is expressed early in the sensory domain 
before hair cells differentiate, but later Ser1/Jag1 is expressed in the supporting cells 
(Adam et al., 1998; Brooker et al., 2006; Cole et al., 2000; Neves et al., 2011). This 
expression pattern is consistent with an early role for Ser1/Jag1 function in 
establishing the pro-sensory fate and a late role in mediating lateral inhibition of the 
hair cell fate (Brooker et al., 2006; Kiernan et al., 2001; Tsai et al., 2001). Forced 
expression of Notch-ICD in the chicken inner ear induces ectopic sensory patches 
with the induction of Ser1 expression (Daudet and Lewis, 2005). Similar phenotypes 
were observed in mouse mutants over-expressing Notch-ICD (Hartman et al., 2010; 
Pan et al., 2010). These results are consistent with the notion of Jag1’s early role. The 
Jag1 conditional knockout mouse (cko) exhibits a loss of outer hair cells and an 
increase in inner hair cell number together with the loss of the cell cycle cyclin-
dependent kinase inhibitor p27Kip1 (Brooker et al., 2006). These hair cell phenotypes 
are also evident in heterozygous Jag1 mutants, although less severe (Kiernan et al., 
2001; Tsai et al., 2001). The more severe loss in outer than inner hair cells is 
attributed to reduced cell proliferation preferentially affecting outer hair cell 





More supporting evidence for the lateral inhibition model in mediating hair 
cell fate comes from analyses of Delta1 and Jag2 knockout mutants, as well as 
mutants lacking downstream effectors of Notch signaling such as Hes1 and Hes5. The 
Delta1 cko mutant exhibits premature production and excess number of hair cells 
consistent with the role for Delta1 in mediating lateral inhibition (Brooker et al., 
2006). In the Jag2 null mutant, both inner and outer hair cells numbers are increased 
and the effect is more profound in Delta1/Jag2 double mutants (Kiernan et al., 2005; 
Lanford et al., 1999). These results are consistent with the lateral inhibitory role for 
these ligands and suggest that Delta1 and Jag2 cooperate with each other and are both 
required for this function (Kiernan et al., 2005). Hes1 and Hes5 are effectors of the 
Notch signaling pathway downstream of Notch-ICD. They belong to the bHLH gene 
family and are repressors of pro-neural bHLH genes during lateral inhibition of the 
neuronal fate. In sensory epithelia of the inner ear, Hes1 and Hes5 negatively regulate 
the expression of the pro-sensory bHLH gene Math1 (also known as Atoh1) in 
supporting cells. Atoh1 is necessary and sufficient for generating hair cells (Woods et 
al., 2004). Hes1 null mutants show an increase in inner hair cell number and Hes5 
nulls have an increase in outer hair cells (Zine et al., 2001). These results are in 
agreement with the expression pattern of Hes1 and Hes5 in the greater and lesser 
epithelial ridges adjacent to the organ of Corti, respectively (Zine et al., 2001).  
 
Sox2’s role in sensory formation 
There is evidence of Sox2’s role in regulation of the sensory fate based on 





expression, respectively (Kiernan et al., 2005). Sensory epithelia are either missing in 
the lcc mutant, or expression of the sensory markers is reduced in the ysb mutant 
(Kiernan et al., 2005). In wildtype, after the initial down-regulation of Sox2 in 
delaminating neuroblasts, Sox2 expression is maintained in the sensory lineage until it 
is again down-regulated during hair cell differentiation but its expression is 
maintained in supporting cells (Dabdoub et al., 2008; Neves et al., 2007). 
Furthermore, Sox2 and Atoh1 are co-expressed in the sensory lineage transiently until 
hair cells start to differentiate (Dabdoub et al., 2008). There is evidence that Sox2 and 
Atoh1 negatively regulate each other. Over-expression of Sox2 in mouse cochlear 
explants leads to an inhibition of hair cell formation while having no effect on 
supporting cells (Dabdoub et al., 2008). Over-expression of Atoh1 in P-19 cell culture 
leads to down-regulation of endogenous Sox2 expression, whereas forced expression 
of Atoh1 in cochlear explants resulted in the induction of hair cell markers and hair 
cells (Dabdoub et al., 2008). Forced expression of Sox2 alone or together with Atoh1 
also in cochlear explants also causes an absence or reduced formation of hair cells 
(Dabdoub et al., 2008). These results suggest an antagonistic relationship between 
Sox2 and Atoh1 in regulating the hair cell fate (Dabdoub et al., 2008). Although this 
dissertation does not address directly Sox2’s role in the sensory lineage and 
development of hair cells, I do provide evidence that Sox2 and the Notch signaling 
pathway potentially interact in mediating cell fate choices between neurons and 







Sox2 is a stem cell factor 
The dual functions of Sox2 in maintaining a proliferative progenitor status 
and mediating differentiation are most crucial during early development. Sox2 is 
expressed in the morula, embryonic stem cells of the inner cell mass of the 
blastocyst, in the epiblast, and in germ cells where it mediates self-renewal and 
pluripotency (Avilion et al., 2003; Chew et al., 2005). In neural stem cells, Sox2 
mediates maintenance of progenitor status, proliferation, and differentiation (Pevny 
and Nicolis, 2010). In the embryonic stem cells of the blastocyst, Sox2, Oct4 (also 
known as Oct3), and Nanog form a close regulatory network through auto-
regulation, cross-regulation, and regulation of down-stream targets, thereby being 
the core regulatory elements (Boyer et al., 2005; Chew et al., 2005; Loh et al., 
2006). Recently, another core set of transcription factors Oct3/4, cMyc, Klf4, 
together with Sox2 have been found to induce pluripotent stem cells from already 
differentiated adult mouse and human fibroblasts (skin cells) (Takahashi et al., 
2007; Takahashi and Yamanaka, 2006). Embryonic stem cells have the unique 
ability to adopt any cell type, to differentiate into all three germ layers, and to grow 
and maintain pluripotency seemingly forever (Boyer et al., 2005; Chew et al., 2005; 
Loh et al., 2006; Takahashi et al., 2007; Takahashi and Yamanaka, 2006). A variety 
of diseases could be potentially treated through the technology of induced patient-
specific somatic cells, and Sox2 is at the forefront of active stem cell and 
regenerative medical research in this context (Takahashi et al., 2007; Takahashi and 






Sox and Sex 
The roles of Sox genes and their homolog Sry in mediating cellular 
differentiation are perhaps best highlighted during sex determination. Mammalian 
sex determination is a complex interplay between intrinsic (e.g. transcription 
factors) and extrinsic factors (e.g. growth factors and signaling molecules) (Bowles 
and Koopman, 2010). During embryonic development, primordial, bipotential germ 
cells, which eventually will give rise to reproductive cells of an egg or sperm, 
migrate from the posterior primitive streak into the developing hindgut (Bowles and 
Koopman, 2010). There, they populate the urogenital ridge, which gives rise to the 
impartial gonads (Bowles and Koopman, 2010). The gonad develops either into a 
testis or an ovary depending on a master switch and on environmental factors 
(Bowles and Koopman, 2010; Collignon et al., 1996; Nagai, 2001; Waters et al., 
2007; Wegner, 1999; Weiss et al., 2003). It has been proposed that the ovary is the 
default pathway, and only in the presence of the master switch together with an 
ovary repressing environmental signal will the gonad develop into a testis (Bowles 
and Koopman, 2010). The master switch has been found to be the Sox gene 
homolog Sry (sex determining region of Y chromosome), which encodes a 
transcription factor, and the environmental signaling molecule is thought to be 
retinoic acid, or rather the degradation of retinoic acid (Bowles and Koopman, 2010; 
Collignon et al., 1996; Nagai, 2001; Waters et al., 2007; Wegner, 1999; Weiss et al., 
2003).  
Sry is expressed in Sertoli cells, which direct the male-specific pathway of 





Without Sry, XX genital ridges develop as ovaries and in the presence of Sry, XY 
ridges as testes (Bowles and Koopman, 2010). Germ cells in the ovary undergo 
meiosis, whereas in the testes they do not and instead arrest in the cell cycle until 
after birth (Bowles and Koopman, 2010). Whether germ cells undergo meiosis or 
not secures the female or the male fate, respectively (Bowles and Koopman, 2010). 
The decisive factor in this case is the degradation of retinoic acid through the 
retinoic acid degradation enzyme Cyp26b1 (Bowles and Koopman, 2010). Retinoic 
acid is thought to induce meiosis and Cyp26b1 is expressed initially in both male 
and female gonads, but then it is up-regulated in the testis and down-regulated in the 
ovary (Bowles and Koopman, 2010). Therefore, the presence of Cyp26b1 prevents 
meiosis and seals the male fate (Bowles and Koopman, 2010). Although Sry is 
thought to be up-stream of Cyp26b1, these two genes are thought to act in different 
pathways (MacLean et al., 2007).  
 The Sox gene family is grouped together based on sequence homology to the 
Sry HMG domain (Collignon et al., 1996; Lefebvre et al., 2007; Nagai, 2001; 
Wegner, 1999). Group B1 Sox genes, Sox1, Sox2, and Sox3, are closest in homology 
to Sry with Sox3 sharing the highest homology (Collignon et al., 1996; Lefebvre et 
al., 2007; Nagai, 2001; Wegner, 1999). Sox3 is located on the X chromosome, 
thereby being the only Sox gene so far located on a sex chromosome (Nagai, 2001; 
Waters et al., 2007). Sox3 is expressed in the urogenital ridge like Sry, and then in 
both male and female genital ridges (Collignon et al., 1996; Waters et al., 2007; 





pluripotency, and its expression has been found in oocytes, suggesting it plays a role 
there as well (Bowles and Koopman, 2010; Collignon et al., 1996; Wegner, 1999).  
It is thought that Sry evolved from an ancestral Sox3 gene because of the 
high HMG sequence homology and because Sox3 is located on the X chromosome 
and Sry is located on the Y chromosome (Nagai, 2001; Waters et al., 2007). The X 
and Y-chromosomes are thought to have evolved from an ancestral autosomal pair 
where the Y chromosome progressively differentiated and lost most of its encoding 
genes and Sry evolved only in mammals (Waters et al., 2007; Wegner, 1999). 
Despite the link between Sry and Sox3, Sox3 is not necessary for sex determination 
but has been found to be important for the normal development of the central 
nervous system, and ovarian and testis development in mice (Weiss et al., 2003). X-
linked mental retardation in humans is associated with mutations in SOX3 (Weiss et 
al., 2003). In mice, Sry is sufficient to induce testis formation in XX animals (Weiss 
et al., 2003). Another Sox gene, Sox9 is also expressed in the male and female 
genital ridges until the onset of Sry expression, and further in the male gonad and 
development of the testes (Wegner, 1999). In humans, mutations in SRY and in 
SOX9 lead to sex reversal in affected XY males, and mutations in SOX9 also lead to 
skeletal deformations (Nagai, 2001; Wegner, 1999; Weiss et al., 2003). All these 
studies illustrate that Sry and Sox genes play crucial roles in mediating 








Aims and Hypotheses 
 The aims of this project are to understand the roles of Sox2 and Sox3 in 
mediating neurogenesis in the inner ear and to understand the potential relationship 
between Sox2 and the Notch signaling pathway in mediating cell fate choices between 
neurons and sensory cells. 
 
Hypothesis 1: Sox3 up-regulates Sox2. Sox2 up-regulates Ngn1 to initiate 
neurogenesis, and Ngn1 inhibits Sox2 expression for neurogenesis to proceed and 
promotes neurogenesis by up-regulating Neurod1 (Fig.1.4).  
                                                           













Hypothesis 2: Notch signaling is up-stream of Sox2 and Sox2 mediates parts of its 
functions via Notch signaling (Fig.1.5). 
 
          
 













                                                           Figure 1.5 
 
Figure 1.5. Hypothesis 2 Model  
Sox2 up-regulates Ngn1 and Delta1 cell-autonomously. The up-regulation of Delta1 
by Sox2 may be direct or indirect through the up-regulation of Ngn1. In order for 
neurogenesis to proceed, the up-regulated Ngn1 inhibits Sox2 activity to activate 
Neurod1, and cell A eventually develops into a neuron. Delta1 binds to the Notch1 
receptor in neighboring cells (cell B) to inhibit the neuronal fate. Upon ligand-
binding, the Notch intracellular domain (Notch-ICD) gets cleaved by γ-secretase. 
Notch-ICD translocates into the nucleus to up-regulate Hes5.1 and presumably Sox2. 
Hes5.1 in turn inhibits Ngn1 and thereby Delta1. Thus, cell B goes on to adopt a 







Experimental Strategy and the Electroporation Method 
 All experiments were conducted in chicken inner ears in ovo. For both gain 
and loss-of-function studies, genes of interest were over-expressed using the 
electroporation method (Fig.1.6). The principle of the electroporation method is based 
on the fact that DNA is negatively charged due to the  PO4- (phosphate) groups in the 
backbone of the DNA molecule. When an electrical current is placed across the DNA, 
the DNA flows toward the anode (positively charged electrode), driving the DNA 
toward a specific area of the tissue of interest. In this case the right otic cup is the 
tissue targeted. The left ear was used as an internal control. This method, though 
widely used, has not been demonstrated to work with high efficiency in the 
developing inner ear. I have devised an electroporation method which yields 
approximately ~80-90% of efficiency in targeting and survival.  
The genes used in this study were sub-cloned into expression vectors that 
express either Green Fluorescent Protein (GFP) or Red Fluorescent Protein (RFP) as a 
marker. The chicken embryos were staged according to developmental stages 
established by Hamburger & Hamilton (1951). The genes were over-expressed at 
stages 10-12 with 10-17 somites at embryonic day 1.5. The ears were analyzed for 
expression of the fluorescent marker within 6-48 hours after electroporation. The ears 
were scored on a scale of 1-3 with a score of 1 for ears with the best expression of the 
fluorescent protein covering the entire ear (see Fig. 1.7 below). Ears with expression 
of the fluorescent marker that included the anterior-ventral NSD such as expression in 
the anterior or ventral half of the ear received a score of 2. Robust expression of the 





harvested. Embryos with scores beyond 3, with poor GFP or RFP expression, were 
not harvested and were discarded. Harvested embryos were processed and analyzed 
for gene or protein expression by RNA in situ hybridization or by 
immunohistochemistry, respectively. Data were statistically quantified where 
appropriate.   
 
                                                           Figure 1.6 
 
Figure 1.6. The Electroporation Method 
The electrodes were made out of two platinum needles, cut, and bent with ~1 mm 
distance between them. The cathode (-) is placed on top of the anode (+). Panel 1 
shows a chicken embryo at approximately ~17 somite stage in ovo. The right otic cup 
(arrow) and left otic cup are visible. The glass capillary needle that holds the DNA 
solution is also visible (outlined with black dashes). The electrodes are initially 





Phosphate Buffered Saline (PBS) to allow easy access with the electrodes. The right 
otic cup is filled with the DNA solution containing 0.1% Fast Green for visualization 
(Panel 2). Then, the electrodes are quickly inserted on the left side sandwiching the 
embryo (Panels 3 and 4). The placement of the electrodes turns the embryo slightly 
toward the left and helps to position the cathode right above the right otic cup (Panel 
4). Then, two pulses at 7 volts with 100 msec duration and spacing are applied (Panel 
4). The electric current opens transient pores in the ear epithelium allowing the DNA 
to be taken up. After the electrodes are removed, one drop of PBS is applied to cool 
down the embryo. The egg is then sealed and returned to the incubator for analysis 
and harvesting between 6-48 hrs. 
 
                                                           Figure 1.7  
 
Figure 1.7. Scoring Strategy. (a-c) Whole-mount ears 24 hrs after electroporation 
with GFP. (a) Score 1 has fluorescent signal in the entire ear including the NSD 
located anterior-ventrally (a, red arrowhead). (b) Score 2 has signal that includes the 
NSD (red arrowhead). (c) Score 3 has signal outside the NSD. The ears are outlined 






Chapter 2: Inhibition of Sox2 transcription by Neurogenin 1 
is required for neurogenesis 
 
Abstract 
In the vertebrate inner ear sensory patches and neurons that innervate them are 
thought to derive from a common neural-sensory competent domain (NSD) at the ear 
rudiment. Sry-related HMG-box 2 and 3 (Sox2, Sox3) are expressed in the NSD but 
their expression is down-regulated in neuroblasts. These expression patterns suggest a 
requirement for Sox2 and Sox3 to be down-regulated for neurogenesis. I addressed the 
roles of Sox proteins in neurogenesis by conducting gain and loss-of-function 
experiments in developing chicken inner ears using an electroporation method. While 
over-expressing Sox2 readily induces Neurogenin 1 (Ngn1) expression, an important 
gene required for specifying the neurogenic fate, the size of the cochleo-vestibular 
ganglion (CVG) is reduced. Over-expression of Ngn1 causes inhibition of Sox2 
transcription, Neurod1 up-regulation, and increased neuroblast formation. Over-
expression of Neurod1 causes similar increases in neuroblast formation. The lack of 
neurogenesis progression is attributed to the inability of Ngn1 to down-regulate an 
exogenous promoter driving Sox2. Furthermore, I provide evidence that Ngn1 and 
Neurod1 inhibit Sox2 transcription via the E-box containing nasal-otic placode-
specific enhancer 1 (NOP1) of the endogenous Sox2 promoter. Despite the induction 
of Ngn1 by Sox2, attempts of loss-of-function approaches suggest that a factor(s) in 









The vertebrate inner ear develops in a precise spatio-temporal manner into a 
highly intricate labyrinth of specialized sensory epithelia of sensory and non-sensory 
components. In chicken, seven sensory epithelia, the utricular macula, saccular 
macula, three cristae, macula neglecta, and the macula lagena, are responsible for 
mediating balance, and one auditory organ, the basilar papilla detects sound. These 
sensory epithelia are arranged in a mosaic of specialized mechanosensory hair cells 
and their associated supporting cells. Cell fate decisions between the sensory and 
neuronal lineages are determined early during inner ear development. First, 
neuroblasts delaminate from the otic neural-sensory competent domain (NSD) to give 
rise to the neuronal subtypes of the cochleo-vestibular ganglion (CVG, VIIIth cranial 
nerve), which extend dendrites to innervate the hair cells in various patches. After 
neuroblast delamination, cells that remain in the NSD are thought to split into various 
sensory patches and develop into hair cells and supporting cells. Fate-mapping studies 
indicate that the neuronal and sensory fates in the inner ear are lineage related (Raft et 
al., 2007; Satoh and Fekete, 2005), even though the molecular mechanisms regulating 








Pro-neural bHLH genes regulate neurogenesis 
 Vertebrate neurogenesis is regulated by a molecular cascade of evolutionary 
conserved basic-Helix-Loop-Helix (bHLH) genes, which encode transcription factors. 
These genes are grouped together into distinct families based on the sequence 
similarity of the bHLH DNA binding domain (Bertrand et al., 2002). This includes 
the families of pro-neural Neurogenin and Neurod genes. The Neurogenin family 
specifies neuronal subtypes whereas the Neurod family promotes differentiation 
(Bertrand et al., 2002; Chae et al., 2004; Ma et al., 1998; Ma et al., 1996). Ectopic 
over-expression of Ngn1 has been shown to lead to ectopic up-regulation of Neurod1 
in Xenopus (Ma et al., 1996). Therefore, Ngn1 is thought to be up-stream of Neurod1. 
Consistently, the Ngn1 null mouse has no Neurod1 expression and the CVG is absent, 
whereas in the Neurod1 null mouse the CVG is much reduced (Liu et al., 2000; Ma et 
al., 2000; Matei et al., 2005). 
 The basic region of the bHLH domain mediates DNA binding to target genes 
and the HLH region mediates dimerization with other members of the bHLH family 
(Markus et al., 2002). The bHLH family of genes are grouped into three classes 
(Markus et al., 2002). Class I makes up the ubiquitously expressed E-proteins, which 
are required within a tissue-specific and cellular-specific context as partners for 
transcriptional activity of the class II members (Markus et al., 2002). Class II 
comprises the pro-neural genes such as Ngn1 and Neurod1, and class III makes up the 
dominant negative repressors, the inhibitors of differentiation and DNA binding (Id) 
proteins (Markus et al., 2002). The pro-neural transcription factors together with E-





The specificity of the interaction of the E-protein and the pro-neural protein at the 
target gene is determined by the specificity of the two central nucleotides within the 
consensus CANNTG E-box motif and by nucleotides flanking this motif (Bertrand et 
al., 2002; Seo et al., 2007). The Id proteins also interact with E-proteins but because 
the Id proteins lack the basic region they cannot bind to the target genes and hence act 
as negative transcriptional regulators (Markus et al., 2002). Although much effort is 
underway in understanding the events of neurogenesis, molecular mechanisms 
initiating neurogenesis and how pro-neural bHLH genes are regulated are unclear 
(Kintner, 2002; Ming and Song, 2005). 
 
Role of Sox2 in organogenesis 
Sox2 is part of a large family of evolutionary conserved transcription factors 
that contain a high-mobility-growth (HMG) DNA binding domain. Sox genes share 
high homology of the HMG domain with the Sry (Sex determining region of Y 
chromosome) gene, which encodes a testis determination factor (Collignon et al., 
1996; Lefebvre et al., 2007; Nagai, 2001; Wegner, 1999). There are about 20 Sox 
genes in vertebrates that are divided into eight groups based on sequence homology 
(Lefebvre et al., 2007). Sox1, Sox2, and Sox3 all belong to group B1 (Lefebvre et al., 
2007). The HMG domain of Sox proteins mediates translocation to the nucleus and 
it partners with other factors for DNA binding to promoter regions of target genes 
(Kamachi et al., 2000; Lefebvre et al., 2007; Wilson and Koopman, 2002). Sox 
family of transcription factors could function as transcription activators or 





al., 2007; Wilson and Koopman, 2002). Sox2 is postulated to function as an 
activator in the development of several organs including the central nervous system, 
taste bud, eye, and lung (Bani-Yaghoub et al., 2006; Bylund et al., 2003; Gontan et 
al., 2008; Okubo et al., 2006; Taranova et al., 2006).  In blastocysts, Sox2 mediates 
self-renewal and pluripotency in embryonic stem cells (Chew et al., 2005). Sox2 
also functions to maintain a proliferative progenitor pool during vertebrate 
neurogenesis, similar to its role as an embryonic stem cell factor (Pevny and 
Nicolis, 2010). However, the expression of Sox2 is down-regulated in the chicken 
neural tube and the mouse neocortex upon neuronal differentiation (Bani-Yaghoub 
et al., 2006; Bylund et al., 2003). There is evidence that suggests the down-
regulation of Sox2 in the chicken neural tube is mediated by bHLH transcription 
factors such as Neurogenin 2 (Ngn2) (Bylund et al., 2003). In the mouse neocortex, 
Sox2 is thought to be degraded specifically in the neuronal lineage by serine 
protease(s) to alleviate Sox2 repression on neurogenesis (Bani-Yaghoub et al., 
2006). Whether this post-translational regulation of Sox2 is a universal mechanism 
for regulating progression of neurogenesis in all neural tissues is not clear.  
The tissue-specific expression of Sox2 is mediated by several identified 
regulatory elements, including the conserved nasal-otic placode-specific enhancers 
1 and 2 (NOP-1 and NOP-2) (Uchikawa et al., 2003). NOP-1 and NOP-2 have been 
shown to be active in the developing chick inner ear (Uchikawa et al., 2003). The 
NOP-1 enhancer has been identified to contain an E-box sequence, whereas NOP-2 
does not contain an E-box (personal communication with Hisato Kondoh). E-boxes 





Blackwell et al., 1993; Seo et al., 2007). E-boxes are binding sites for bHLH 
transcription factors of E-proteins together with pro-neural bHLH factors such as 
Ngn1 and Neurod1 (Markus et al., 2002). Pro-neural bHLH transcription factors 
require the interaction of E-proteins to regulate the expression of target genes 
though the E-box motif (Markus et al., 2002). In this study, I investigated whether 
there is an interaction of Ngn1 and Neurod1 with the NOP-1 enhancer. Since the 
NOP-2 enhancer is not conserved between chicken and mouse (personal 
communication with Hisato Kondoh) and the fact that NOP-2 does not contain an E-
box, making it an unlikely target binding site for bHLH proteins, experiments with 
NOP-2 were not pursued further in this study. 
 
Mutations in the SOX2 gene lead to sensorineural hearing loss in humans and 
loss of Sox2 function leads to deafness in mice (Hagstrom et al., 2005; Kiernan et al., 
2005). Here, I sought to address the role of Sox2 and Sox3 in regulating neuronal fate 
specification using gain and loss-of-function experiments in developing chicken inner 
ears. I show that while over-expressing Sox2 readily induces Ngn1 expression, the 
size of the CVG is reduced. Over-expression of Ngn1 inhibits Sox2 transcription, 
induces Neurod1 expression, and leads to increased neuroblast formation. Over-
expression of Neurod1 is sufficient for neurogenesis. I provide evidence that Ngn1 
and Neurod1 inhibit Sox2 at the transcriptional level via the E-box containing NOP-1 
enhancer of the Sox2 promoter. Furthermore, my loss-of-function results suggest that 
Sox2 may potentially be required in the NSD for neurogenesis. I propose that Sox2 





one of the important roles of pro-neural bHLH proteins is to inhibit Sox2 transcription 
in order for neurogenesis to proceed. While Sox3 has been proposed to be up-stream 
of Sox2, it does not induce Ngn1 in a similar manner as Sox2. 
 
Materials and Methods 
Eggs, in ovo Electroporation, and Expression Constructs 
Fertilized chicken eggs (B&E York Springs, PA) were incubated at 38° C 
and staged according to Hamburger and Hamilton (Hamburger and Hamilton, 
1992). Full-length cDNA of chicken Sox2 and Sox3, as well as the region encoding 
the HMG domain of Sox2 and Sox3 fused to the Drosophila Engrailed repressor 
domain (HMG-EnR), and the HMG domain of Sox2 fused to the Herpes simplex 
viral protein 16 activator domain (HMG-VP16) were subcloned into the pMES-
IRES-GFP expression vector, in which various cDNA is driven by a chicken β-actin 
promoter. The internal ribosomal entry site (IRES) mediates bicistronic expression 
of the Green Fluorescent protein. Mouse Ngn1 cDNA was subcloned into pMES-
IRES-GFP and pCMV-DsRed-Express (Clontech) vectors. Chicken Neurod1 was 
sub-cloned into the pCI-IRES-H2B-RFP vector. The NOP-1, and NOP1-Ebox 
Mutant (E-box sequence CAGGTG mutated to AGCTAA) enhancers of Sox2 were 
subcloned into an Enhanced Green Fluorescent Protein vector, ptkEGFPv2. Various 
plasmids were delivered to the right otic cup in ovo between 10-17 somite stages 
(E1.5) by electroporation. This was conducted by filling the right otic cup with 
plasmids at a concentration of 3-5 µg/µl in 0.1% Fast Green. Then, a negative 





inserted underneath the embryo at the location of the left otic cup. Two pulses at 7 
volts with 100 msec duration and spacing were applied using a CUY21 
electroporator. Then, the eggs were sealed and returned to the incubator between 6 
to 48 hrs before harvesting. For co-electroporations, the respective plasmid 
constructs were used at approximately 3 µg/µl concentrations each.  
For consistency throughout the study the constructs are named as follows (also see 
Table 2.1 below): GFP, Sox2-GFP, Sox3-GFP, Ngn1-GFP, EnR(Sox2)-GFP, 
EnR(Sox3)-GFP, VP16(Sox2)-GFP, DsRed, Ngn1-DsRed, RFP, Neurod1-RFP, 
NOP1-GFP, and NOP1-EboxMut-GFP. 
 
Table 2.1 List of constructs and proteins they encode 
pMES-IRES-GFP Dicistronic expression of Green 
Fluorescent Protein driven by a chicken 
β-actin promoter 
pMES-Sox2-IRES-GFP Full-length chicken Sox2 driven by a 
chicken β-actin promoter 
pMES-Sox3-IRES-GFP Full-length chicken Sox3 driven by a 
chicken β-actin promoter 
pMES-Ngn1-IRES-GFP Full-length mouse Ngn1 driven by a 
chicken β-actin promoter 
pMES-HMGEnR(Sox2)-IRES-GFP HMG domain of Sox2 fused to 
Drosophila Engrailed repressor domain 
driven by a chicken β-actin promoter 
pMES-HMGEnR(Sox3)-IRES-GFP HMG domain of Sox3 fused to 
Drosophila Engrailed repressor domain 





pMES-HMGVP16(Sox2)-IRES-GFP HMG domain of Sox2 fused to Herpes 
simplex viral protein 16 activator 
domain driven by a chicken β-actin 
promoter 
pCMV-DsRed-Express-Ngn1 Mouse Ngn1 fused to Red Fluorescent 
Protein driven by a cytomegalovirus 
promoter 
pCI-IRES-H2B-RFP Dicistronic expression of Red 
Fluorescent Protein driven by a chicken 
β-actin/rabbit β-globin hybrid promoter 
and a cytomegalovirus enhancer, as 
well as histone 2B for nuclear 
localization  
pCI-Neurod1-IRES-H2B-RFP Full-length chicken Neurod1 driven by 
a chicken β-actin/rabbit β-globin hybrid 
promoter and a cytomegalovirus 
enhancer, as well as histone 2B for 
nuclear localization 
ptk-Nop1-EGFPv2 NOP1 enhancer fused with Enhanced 
Green Fluorescent Protein and 
thymidine kinase cassette 
ptk-Nop1EboxMut-EGFPv2 E-box within NOP1 enhancer mutated 
fused with Enhanced Green Fluorescent 
Protein and thymidine kinase cassette 
 
In situ hybridization 
Whole mount and section in situ hybridization were carried out as previously 
described (Raft et al., 2007; Wu and Oh, 1996). Chicken Dig-labeled anti-sense 





Double labeling of tissue sections with in situ and Immunohistochemistry 
           To analyze gene expression at a cellular level, ear sections were first probed 
for RNA transcripts (e.g. Ngn1), followed by labeling with rabbit polyclonal-anti-
GFP antibody (1:500 Invitrogen) overnight at 4° C. The time for Proteinase K 
treatment during the in situ procedure was reduced to 1 min and the time for 
colorimetric development was also monitored and terminated when the color 
precipitates first became evident to avoid hindering subsequent immunostaining 
signals. The secondary antibody was goat anti-rabbit Alexa Fluor 488 (1:250 
Invitrogen). Antibody labeling was performed according to standard protocol (Raft 
et al., 2007). 
 
Immunohistochemistry 
           Cryo-sections were prepared as described above for in situ hybridization. The 
primary antibodies used were rabbit polyclonal anti-Sox2 (1:4000 Chemicon), goat 
polyclonal anti-GFP-FITC-(conjugated) (1:400 GeneTex), rabbit polyclonal anti-
DsRed-Express (1:100 Clontech), and mouse monoclonal anti-Neuron-specific β-III 
Tubulin-Nothern Lights 557-(conjugated) (TuJ-1-NL557, 1:25 R&D Systems). The 
secondary antibodies were goat anti-rabbit Alexa Fluor 568 (1:250 Invitrogen), goat 
anti-rabbit Alexa Fluor 680 (1:250 Invitrogen), and goat anti-rabbit Alexa Fluor 488 
(1:250 Invitrogen). Antibody labeling was performed according to standard protocol 
(Raft et al., 2007), except the sections were subjected to antigen retrieval by citrate 







           For analyzing the size of ganglia after electroporation, serial ear sections 
were subjected to Neurod1 in situ hybridization and photographed with a Zeiss 
microscope. The outlines of the Neurod1-positive ganglionic regions and the otocyst 
were traced, and the areas were summed and computed using NIH image J software. 
Two-tailed Student’s t-tests were performed between control and treated samples. 
           For analyzing the enhancer activity of Sox2 in the presence of Ngn1, NOP1-
GFP, or NOP1-EboxMut-GFP was co-electroporated with Ngn1-DsRed or DsRed 
control. Similar experiments were conducted with Neurod1-RFP. Ear sections were 
subjected to double antibody labeling against anti-GFP-FITC and anti-DsRed-
Express, counterstained with DAPI, and photographed with a Zeiss microscope. The 
images were merged in Adobe Photoshop and the total number of cells that co-
expressed anti-GFP-FITC and anti-DsRed-Express per ear were counted. Two-tailed 
Student’s t-tests were performed on the total number of co-expressing cells. For 
analysis of NOP-1 activities within the NSD, sections adjacent to the ones processed 
for double antibody labeling of anti-GFP and anti-DsRed were probed for Ngn1 
transcripts by in situ to identify the NSD. Double-labeled cells within the NSD were 
scored and a two-tailed Chi-Square test was used for quantification. 
 
Results  
Sox2 is expressed in the NSD and overlaps in expression with Sox3 and Lfng 
  I sought to address the expression patterns of Sox2 and Sox3 at early stages 





hybridization. Figure 2.1 illustrates the overlapping expression patterns of Sox2, 
Sox3 (Fig. 2.1a, b, g, and h) and Lfng (Fig. 2.1d) in the presumed NSD located in the 
anterior ventral region of the chicken otic cup and otocyst. While Ngn1 is also 
expressed in the NSD (Fig. 2.1c), its expression is only localized in a sub-set of cells 
within the domain (Fig.2.1d). Notably, both Sox2 and Sox3 are only weakly 
expressed in the delaminated neuroblasts of the CVG (Fig. 2.1e and f). Based on the 
over-lapping expression pattern of Sox2 and Sox3 in the NSD and their subsequent 
down-regulation in the CVG, I hypothesized that both Sox2 and Sox3 play a role in 
regulating the neuronal fate.  
 
         Figure 2.1 
 
Figure 2.1. Expression patterns of Sox2, Sox3, Ngn1, and Lfng in the otic cup 





expressed within the Lfng-positive NSD (a-d, g and h; red arrowheads). At the 
otocyst stage, Sox2 expression persists in the sensory patches (e), whereas Sox3 is 
down-regulated in sensory epithelia (f). Both Sox2 and Sox3 are only weakly 
expressed in the delaminated neurons of the CVG (e and f; white arrowheads). ss, 
somite stages; E, embryonic day.  
 
Ectopic Sox2 causes a decrease in the size of CVG but an up-regulation of Ngn1  
            I investigated the role of Sox2 in neurogenesis by over expressing Sox2 in 
the developing inner ear.  Inner ears electroporated with Sox2-IRES-GFP (Sox2-
GFP) or control (GFP) plasmid at otic cup stages were analyzed for GFP signal 
within 24 and 48 hrs after electroporation. Sox2-GFP treated ears appear to have a 
smaller CVG (Fig. 2.2b, b’). Some of the 48 hrs specimens were subsequently 
sectioned, processed for in situ hybridization of Neurod1 transcripts, and used to 
quantify the size of the otocyst and ganglion (see Materials and Methods). While 
there is no difference in the size of the otocyst between the right electroporated and 
the left non-electroporated ears and there is no significant difference in the size of 
CVG between non-electroporated and GFP control ears, there is an approximately 
50% reduction in the size of Sox2-GFP treated CVGs compared to GFP controls 
and untreated controls (Fig. 2.2c).  
            The decrease in CVG size suggested an inhibition of neurogenesis by over-
expressing Sox2. This led me to analyze the expression patterns of Ngn1 and 
Neurod1 in Sox2-GFP specimens. Unexpectedly, Sox2-GFP treated ears show 
ectopic expression of Ngn1 in GFP positive regions within (Fig. 2.2f, f’) as well as 





with the GFP-positive domains, suggesting the up-regulation is cell-autonomous 
(Fig.2.2e, f; arrowheads). This up-regulation is also rapidly detectable within 6-7 hrs 
after electroporation (Fig. 2.3), suggesting a possible direct effect of Sox2 on Ngn1. 
In contrast, while GFP positive cells are present throughout the otic epithelium in 
GFP controls, no up-regulation of Ngn1 is observed (Fig. 2.2d, d’).  Notably, 
despite the up-regulation of Ngn1, there is no concomitant up-regulation of Neurod1 
in the Sox2-treated ears 48 hrs after electroporation (not shown), which suggests 
there is no progression of neurogenesis beyond Ngn1 expression and this result is 
consistent with the finding of reduced CVG sizes. 
 

















                                                            Figure 2.2 
 
Figure 2.2. Over-expression of Sox2 leads to a decrease in the size of CVG but an 
ectopic cell-autonomous up-regulation of Ngn1. (a-b’) Otocysts electroporated with 
GFP or Sox2-GFP at 24 hrs and 48 hrs. The otocyst is outlined in red. Red arrows 
point to the presumably delaminated neuroblasts. GFP control ears show more 
neuroblast delamination than Sox2-GFP ears at both 24 and 48 hrs. (c) Quantitative 





non-electroporated control ears, whereas CVGs of Sox2-treated ears are 
approximately 50% smaller than controls and GFP-treated ears. Student’s t-test * 
p=0.0068; ** p=0.000084; error bars represent s.e.m.. (d-f’) Sectioned GFP control 
and Sox2-GFP treated ears double-labeled for Ngn1 transcripts and anti-GFP 
antibody 48 hrs after electroporation. GFP control ears (n=2) show Ngn1 expression 
in the NSD and in delaminating neuroblasts that are double-labeled with anti-GFP (d, 
d’; red arrowheads). In Sox2-GFP ears (n=4/5) double-labeled cells are present in 
dorsal (e, e’) as well as ventral (NSD, f, f’) otic regions (red arrowheads).  
 






Figure 2.3. Over-expressing Sox2-GFP leads to Ngn1 up-regulation by 6-7 hrs. 
Otic cups electroporated with GFP control or Sox2-GFP at 6-7 hr harvest (a, c; 
inset). Ears are outlined in red and the level of section is indicated in white lines (a, 
c; insets). Adjacent sections probed for GFP and Ngn1 (a-d). Ngn1 expression is up-
regulated in the NSD (d, red bracket) as well as other regions outside the NSD (d, 
white bracket) in Sox2-treated ears (n=7/7) compared to GFP control (b, NSD red 
bracket; n=7). 
 
Ngn1 is sufficient to promote neurogenesis and up-regulate Neurod1 
            Despite the observed up-regulation of Ngn1 in Sox2 treated specimens, 
neurogenesis fails to proceed.  This led me to investigate the consequence of over-
expression of Ngn1. Similar electroporated experiments conducted with Ngn1-IRES-
GFP (Ngn1-GFP) show broad ectopic cell delamination beyond the NSD from all 
over the otocyst within 24 hrs (Fig. 2.4a-b). Delamination is more evident by 48 hrs, 
to the extent that the otocysts are malformed and smaller in size (Fig. 2.4b’, m). 
Section analyses indicate that the delaminated cells are indeed neuroblasts based on 
Neurod1 expression (Fig. 2.4n, q).  The ectopic expression of Neurod1 and the 
subsequent delamination of these cells could be a result of an expansion of the NSD.  
However, there is no obvious expansion of the NSD based on Lfng expression (Fig. 
3i, l, o, r; n=15). Since a majority of the GFP-positive cells appear to have 
delaminated from the otic epithelium already in the Ngn1-GFP specimens by 48 hrs, 
I harvested some specimens at 15 hrs after electroporation to confirm the ectopic 





not observed in the Sox2-GFP specimens. The induction of Neurod1 by Ngn1 is 
consistent with previous reports that Ngn1 is up-stream of Neurod1 (Ma et al., 
1996). Together, these results show that over-expressing Ngn1 is sufficient to up-
regulate Neurod1 and induce neurogenesis in the inner ear. 
 






















                                                           Figure 2.4 
 
Figure 2.4. Ngn1 is sufficient to promote neurogenesis and up-regulate Neurod1. 





and 48 hrs (a’, b’). The outline of the otocyst is indicated in red.  Red arrows point to 
the presumably delaminated neuroblasts. Ngn1-GFP ears show neuroblast 
delamination from the NSD (b’ red arrows) as well as ectopically from other regions 
of the otocyst (b, b’; white arrows) compared to GFP ears. Adjacent tissue sections 
probed for GFP and Neurod1 transcripts in GFP control (c, d) and Ngn1-GFP (e, f) 
treated ears 15 hrs after electroporation. Neurod1 expression is up-regulated in the ear 
epithelium in Ngn1-GFP treated ears (f, n= 8/10) but not in the GFP control (d, n=7). 
Adjacent tissue sections probed for GFP, Neurod1, and Lfng transcripts in GFP 
control (g-l) and Ngn1-GFP (m-r) treated ears 48 hrs after electroporation. In the 
GFP control ears Neurod1 is expressed only in the CVG (h, k; red arrowheads; n=10) 
and the Lfng-positive NSD (k, l), but not outside of the NSD (h) that is Lfng-negative 
(i). In Ngn1-GFP ears, Neurod1-positive neuroblasts are detected in both dorsal and 
ventral sections anterior and posterior to the otic epithelium (n, q; white arrowheads; 
n=4/4). Neurod1 is expressed in the NSD (q) that overlaps with the Lfng domain (r). 
Despite the ectopic, delaminated Neurod1-positive cells dorsally, there is no 
expansion of the Lfng domain (m, n, o).  
 
Over-expressing Ngn1 leads to down-regulation of Sox2  
            In the chicken neural tube, Ngn2 inhibits Sox2 expression (Bylund et al., 
2003). To test if a similar relationship occurs in the inner ear, I have analyzed Ngn1-
GFP treated ears for Sox2 expression at 15 hrs after electroporation. Cells double-
labeled for GFP and Sox2 immunoreactivity are present in the NSD of GFP 





ears do not show Sox2 immunostaining (Fig. 2.5). These results suggest that over-
expression of Ngn1 leads to a down-regulation of Sox2 similar to findings in the 
chicken neural tube and further suggests that there may be a requirement for Sox2 to 
be down-regulated by Ngn1 for neurogenesis to proceed in the developing inner ear 
as well. 
                                                           
                                                             Figure 2.5 
 
Figure 2.5. Over-expressing Ngn1 leads to down-regulation of Sox2. 
Wholemounts (a, c) and sections (b, d) of GFP control (a-b’) and Ngn1-GFP  (c-d’) 
treated ears. Sections of GFP control and Ngn1-GFP treated ears double-labeled 





GFP control ears show Sox2 immunostaining in the NSD (b’ white brackets; n=4), 
in which some of the cells are GFP positive. (d) The GFP-positive region in Ngn1-
GFP ears show down-regulated Sox2 immunostaining (d’ asterisk; n=4/5), but 
staining in the neural tube is similar to controls (b’, d’; white arrowheads). Ngn1-
GFP electroporated ears often show a delay in otic cup closure (c, d, d’). The ears 
are outlined in red (a, c), and the levels of sectioning are indicated in white lines (a, 
c).  
 
NOP-1 enhancer of Sox2 is inhibited by exogenous Ngn1 
             The tissue-specific expression of Sox2 is mediated by multiple regulatory 
elements within the Sox2 promoter, which includes the conserved nasal-otic 
placode-specific enhancer 1 (NOP-1), which confers expression in the developing 
chicken inner ear (Uchikawa et al., 2003). To test if Ngn1 might inhibit Sox2 
transcription at the NOP-1 site, NOP-1 tagged with EGFP (NOP1-GFP), or NOP-1 
with a mutation in E-box (NOP1-EboxMut-GFP) were co-electroporated to the otic 
cup in the presence or absence of Ngn1-DsRed and samples were analyzed 15 hrs 
after electroporation and the total number of anti-GFP and anti-DsRed co-
expressing cells per ear were quantified (Fig. 2.6). The GFP activity driven by the 
NOP-1 enhancer activity is significantly reduced in the presence of Ngn1-DsRed 
compared to control (Fig. 2.6c). However, GFP activity driven by NOP-1 with a 
mutated E-box, NOP1-EboxMut-GFP, is not significantly reduced (Fig. 2.6f). These 






            Figure 2.6 
 
Figure 2.6. Ngn1 inhibits NOP-1 activity. Ears co-electroporated with NOP1-GFP 
(a-b’’) or NOP1-EboxMut-GFP (d-e’’) with DsRed control (a-a’’; d-d’’) or Ngn1-
DsRed (b-b’’; e-e’’) 15 hrs after electroporation. Ear sections were double-labeled 
with anti-GFP and anti-DsRed, and counterstained with DAPI (not shown). Images 
were merged in Adobe Photoshop (a’’, b’’, d’’, e’’). Total number of GFP and DsRed 
co-labeled cells were quantified (c, f). The activity of NOP1-GFP is significantly 
reduced in the presence of Ngn1-DsRed compared to controls ** p=0.00036; error 





affected by Ngn1-DsRed compared to controls, p=0.49; error bars represent s.e.m. (f). 
The level of sections is indicated in the schematic. NT, neural tube; OC, otic cup.                  
 
Neurod1 is sufficient to promote neurogenesis and inhibits NOP-1 activity 
Neurod1, which is thought to be activated by Ngn1 (Ma et al., 1996), has been 
shown to be required for the formation of the CVG (Liu et al., 2000). To test if 
Neurod1 is able to induce neurogenesis similar to Ngn1, Neurod1-IRES-RFP 
(Neurod1-RFP) or IRES-RFP (RFP) control were electroporated at the otic cup stage 
and harvested 48 hrs later (Fig. 2.7). Neurod1-RFP ears show double-labeled DsRed 
and TuJ1-positive cells delaminating from within and ectopically outside the NSD 
(Fig. 2.7e, e’, f, f’) compared to RFP control (Fig.2.7b-c”). Therefore, expression of 
Neurod1 is also sufficient to mediate neurogenesis in the developing inner ear.   
In addition, I tested if Neurod1 is also capable of inhibiting NOP-1 activity. 
Similar NOP1-GFP or NOP1-EboxMut-GFP experiments were conducted with 
Neurod1-RFP (Fig. 2.7). The NOP1-GFP enhancer activity is significantly reduced in 
the presence of Neurod1-RFP compared to control (Fig. 2.7i), whereas the NOP1-
EboxMut-GFP activity is not (Fig. 2.7l). These findings suggest that Neurod1 is 










                                                           Figure 2.7 
 
Figure 2.7. Neurod1 is sufficient to promote neurogenesis and inhibits NOP-1 
activity. Otocysts electroporated with RFP (a) or Neurod1-RFP (d) at 48 hrs after 
electroporation. Ears are outlined and levels of sections are indicated in white. Ear 





counterstained with DAPI (b-b’’, c-c’’, e-e’’, f-f’’). Neurod1-RFP treated ears show 
double-labeled ectopic DsRed and TuJ1-NL-positive neuroblast delamination (e, e’; 
yellow arrowheads) as well as increased delamination form the NSD (f, f’; yellow 
arrowheads) compared to control (c, c’; white arrowheads). Ears co-electroporated 
with NOP1-GFP (g-h’’) or NOP1-EboxMut-GFP (j-k’’) with RFP control (g-g’’; j-
j’’) or Neurod1-RFP (h-h’’; k-k’’) 15 hrs after electroporation. Ear sections were 
double-labeled with anti-GFP and anti-DsRed, and counterstained with DAPI (not 
shown). Images were merged in Adobe Photoshop (g’’, h’’, j’’, k’’). Total number of 
GFP and DsRed co-expressing cells were quantified (i, l). The activity of NOP1-GFP 
is significantly reduced in the presence of Neurod1-RFP compared to controls ** 
p=0.0013; error bars represent s.e.m. (i). The activity of NOP1-EboxMut-GFP is not 
significantly affected by Neurod1-RFP compared to controls, p=0.12; error bars 
represent s.e.m. (l). The level of sections is indicated in the schematic. NT, neural 
tube; OC, otic cup. 
 
The activity of NOP-1 is inhibited within the endogenous Ngn1-positive domain 
Next, I asked if the inhibition of NOP-1 by Ngn1 or Neurod1 is biologically 
relevant and could be inhibited by the level of endogenous pro-neural bHLH factors.  
Therefore, I focused my analyses of NOP1-GFP or NOP1-EboxMut-GFP 
electroporated specimens only in the NSD, where Ngn1 and Neurod1-positive cells 
are normally expressed (Fig. 2.8). The total numbers of anti-GFP and anti-DsRed 
co-expressing cells in the NSD were scored for quantification (see Materials and 





compared to the control NOP-1 with a mutated E-box (Fig. 2.8e). These findings 
indicate that endogenous levels of pro-neural bHLH factors are capable of inhibiting 
NOP-1 activity.  
                                              
                                                Figure 2.8 
 
Figure 2.8. The activity of NOP-1 is inhibited within the NSD. Ears co-
electroporated with NOP1-EboxMut-GFP and RFP as control (a-b’’) or NOP1-GFP 
and RFP (c-d’’) 15 hrs after electroporation. Adjacent sections probed either for Ngn1 
transcript or double-labeled against anti-DsRed and anti-GFP (a, b and c, d) and 
counterstained with DAPI (not shown). Images were merged in Adobe Photoshop 





Ngn1-postive area were quantified (e). The activity of NOP1-GFP is significantly 
reduced in the Ngn1-positive domain compared to the control *** p<0.0001; χ2=591 
(e). The level of sections is indicated in the schematic. NT, neural tube; OC, otic cup. 
 
Over-expression of Sox3 has no effect on Ngn1 expression or neurogenesis 
               Similar to Sox2, Sox3 is also expressed in the NSD (Fig. 2.1). Sox3 has 
been shown to up-regulate Sox2 in the developing chicken inner ear (Abello et al., 
2010). To address whether Sox3 has a similar function in regulating neurogenesis as 
Sox2, similar experiments were conducted using a Sox3-GFP construct. Over-
expression of Sox3 does not induce Ngn1 expression inside or outside of the NSD 
(Fig.2.9). It also has no apparent effect on Neurod1 expression (not shown, n=6), or 
the size of the CVG (not shown, n=8). Therefore, despite the induction of Sox2 by 
ectopic Sox3, Sox3 does not have a similar effect on neurogenesis as Sox2 in these 
experimental paradigms. 
             
 











                                               Figure 2.9 
 
Figure 2.9 Over-expressing Sox3 is insufficient to up-regulate Ngn1. Otic cups 
electroporated with GFP control or Sox3-GFP at 15 hr harvest (a, c; insets). The 
ears are outlined in red and the level of sectioning is indicated in white lines (a, c; 
insets). Adjacent sections probed for GFP and Ngn1 transcripts (a-d). Similar Ngn1 
expression within the endogenous NSD (b, d; red brackets) in both control (b; n=3) 
and Sox3-treated ears (d; n=5). No Ngn1 up-regulation outside the NSD is observed 








Sox2 appears to act as a repressor 
              It is well established that Sox proteins can function as a transcription 
activator or repressor (Kamachi et al., 2000; Lefebvre et al., 2007; Wilson and 
Koopman, 2002). Two previously published constructs used successfully to 
demonstrate Sox2 and Sox3 proteins functioning as activators in the neural tube 
were employed (see (Bylund et al., 2003)): an obligatory repressor version of Sox2, 
EnR(Sox2)-GFP, in which the HMG domain of Sox2 is fused to the Drosophila 
Engrailed repressor domain and IRES-GFP, and an activator version of Sox2, 
VP16(Sox2)-GFP, in which the HMG domain of Sox2 is fused to the activator 
domain of Herpes simplex viral protein 16 and IRES-GFP. Over-expression of 
EnR(Sox2)-GFP shows that there is an approximately 32-50 % reduction in the size 
of the CVGs compared to controls (Fig.2.10), similar to ears over-expressing Sox2. 
In addition to the reduction in CVG sizes, section analyses indicate that there is an 
ectopic up-regulation of Ngn1 dorsally outside the NSD and an up-regulation within 
the NSD in some specimens analyzed at different time points of harvests (shown at 
20 hr harvest in Fig.2.11). This increase in Ngn1 expression is very robust in 
specimens co-electroporated with EnR(Sox2)-GFP and EnR(Sox3)-GFP (not shown, 
n=4/5). Although Sox3-GFP alone (Fig.2.9) or EnR(Sox3)-GFP alone-treatments 
(not shown) have no obvious effect on Ngn1 expression or the sizes of the CVG (not 
shown), the combined effects of EnR(Sox2)-GFP and EnR(Sox3)-GFP on Ngn1 up-
regulation suggest that these proteins function co-operatively with each other. 
             So far, my results suggest that Sox2 is functioning as a repressor in the inner 





over-expression of VP16(Sox2) also showed ectopic, dorsal up-regulation of Ngn1 
but for the most part no change in expression within the NSD (Fig.2.12). It is not 
clear why both EnR(Sox2) and VP16(Sox2) induce Ngn1 expression ectopically 
outside the NSD (see Discussion). Nevertheless, my results are more consistent with 
Sox2 functioning as a repressor within the NSD because of the similarity in 
phenotypes obtained between specimens with over-expression of Sox2 and 
EnR(Sox2). The lack of down-regulation of Ngn1 in VP16(Sox2) specimens could 
be attributable to other factors regulating Ngn1 expression in addition to Sox2. 
 
                                                            Figure 2.10 
 
Figure 2.10. EnR(Sox2) causes a reduction in the size of the CVG. Otocysts 
electroporated with GFP (a, a’) or EnR(Sox2)-GFP (b, b’) at 24 hrs (a, b) and 48 hrs 
(a’, b’). The outline of the otocyst is indicated in red. Red arrows point to the 
presumably delaminated neuroblasts. GFP control ears show more neuroblast 





analysis of CVG sizes. CVGs of GFP treated ears are not significantly different than 
non-electroporated ears, whereas CVGs of EnR(Sox2)-treated ears are approximately 
32-50% smaller than controls. Student’s t-test * p=0.015 ** p=0.0017; error bars 
represent s.e.m..  
 
                                                           Figure 2.11 
 
Figure 2.11 EnR(Sox2) causes Ngn1 up-regulation within and outside the NSD. 
Otic cups over-expressed with GFP (a, b) or EnR(Sox2)-GFP (c, d) at 20 hr harvest. 
The ears are outlined in red and levels of sectioning are indicated in white lines (a, c; 
insets). Adjacent sections probed for GFP and Ngn1 transcripts (a-d). Ngn1 





treated ears (d, white brackets; n=3/4) compared to GFP controls (b, red bracket; 
n=2). 
                                                         Figure 2.12 
 
Figure 2.12 VP16(Sox2) causes only up-regulation of Ngn1 outside the NSD. 
Otic cups over-expressed with GFP (a, b) or VP16(Sox2)-GFP (c, d) at 20 hr 
harvest. The ears are outlined in red and levels of sectioning are indicated in white 
lines (a, c; insets). Adjacent sections probed for GFP and Ngn1 transcripts (a-d). (e) 
Ngn1 expression in left untreated ear of the specimen in (c). Ngn1 expression 
appears unchanged within the NSD (d, red bracket), but up-regulated outside the 
NSD (d, white bracket) in VP16(Sox2)-treated ears (n=4/5) compared to left 
untreated control (e, red bracket) and GFP controls (b, red bracket; n=2). 





                                                         Figure 2.13 
 
Figure 2.13 Summary Model 
Sox2 activity together with other potential unknown factors (X, Y, and Z) up-
regulate Ngn1 within the NSD. Ngn1 initiates neurogenesis by inhibiting Sox2 
transcription and thus up-regulates Neurod1, which is an obligatory step for 
neurogenesis. Neurod1 further inhibits Sox2 transcription. 
 
Discussion 
Sox2’s role in neurogenesis 
        Vertebrate neurogenesis is regulated by a molecular cascade of pro-neural 
bHLH transcription factors including Ngn1 and Neurod1 (Kintner, 2002). The 
current dogma of neurogenesis in the vertebrate CNS is that neural stem cells 
proliferate and undergo self-renewal. Over time these stem cells develop into 
progenitors, which subsequently become specified and lineage restricted into 





the neuronal fate lineage and Neurod1 mediates the differentiation of neuroblasts 
into neuronal subtypes (Bertrand et al., 2002; Chae et al., 2004; Ma et al., 1998; Ma 
et al., 1996). It is unclear how neural stem cells progress into becoming neuronal 
progenitors and then become lineage restricted into neurons and glia. However, 
growth factors and mitogens such as fibroblast growth factors (Fgf’s) and Sonic 
hedgehog (Shh) are thought to play a role in the proliferation of the neural stem 
cells, and Bone morhpogenetic proteins (Bmp’s) and Shh are thought to play a role 
in the progression from neural stem cell to neuronal progenitor pool (Kintner, 2002; 
Ming and Song, 2005). It is also unclear how pro-neural bHLH genes themselves 
are regulated (Kintner, 2002). Sox2’s role is to maintain a self-renewing, 
proliferating neural stem cell pool (Pevny and Nicolis, 2010). Accumulating 
evidence suggests that Sox2 expression is down-regulated in the neuronal lineage 
upon differentiation, but maintained in expression in the glial lineage, i.e. down-
regulation of Sox2 appears to be a pre-requisite for the occurrence of neurogenesis, 
while Sox2 function is required for the generation of glia (Bani-Yaghoub et al., 
2006; Cavallaro et al., 2008). Compared to previous reports, the up-regulation of 
Ngn1 by Sox2 in the developing inner ear is an unexpected finding. For instance, 
over-expression of Sox2 in the chicken neural tube has led to no detectable changes 
in Ngn1 or Ngn2 expression (Bylund et al., 2003). However, a binding site for Sox2 
has been identified within the Ngn1 promoter using chromatin immunoprecipitation 
analyses (Okuda et al., 2010). This binding site has been proposed to be involved in 
the up-regulation of Ngn1 during early embryogenesis in zebrafish, since knock-





system (Okuda et al., 2010). Furthermore, in the developing Xenopus retina, a 
specific Frizzled trans-membrane receptor, Fz5, which is involved in Wnt/β-catenin 
signaling, has been demonstrated to be up-stream of Sox2 (Van Raay et al., 2005). 
In this case, knock-down of Fz5 leads to loss of Sox2 and expression of neuronal 
genes such as Ngn1 (Van Raay et al., 2005). These results suggest that the Wnt/β-
catenin signaling pathway regulates retinal neuronal fate specification indirectly by 
regulating Sox2 expression (Van Raay et al., 2005). Here, the activation of Ngn1 
expression by Sox2 in the developing inner ear suggests that Sox2 is involved in 
initiating the molecular cascade of pro-neural bHLH genes required for 
neurogenesis. Both Ngn1 and Neurod1 engage in an inhibitory feed-back loop in 
inhibiting Sox2, which is required for the progression of neurogenesis. It will be 
interesting to see if Sox2 functions in a similar context in other placode-derived 
sensory organs such as the olfactory placode and the trigeminal ganglion (Streit, 
2008).  
          Although previous studies have tried to address Sox2’s role during 
neurogenesis and assigned its function as inhibitory to neurogenesis, the molecular 
mechanism has remained unclear (Bani-Yaghoub et al., 2006; Bylund et al., 2003). 
Contrary to this assigned role, recent studies suggested that Sox2 is a pro-neural 
gene in the inner ear based on the positive effects of Sox2 on neuronal formation in 
mouse cochlear cultures, specifically in the Kolliker’s organ (Puligilla et al., 2010). 
However, my results suggest that while Sox2 may be required for neurogenesis it 
needs to be inhibited in order for neurogenesis to proceed. Based on my results, 





demonstrated previously that cells in the Kolliker’s organ are derived from the 
Ngn1-positive cells in the NSD. This lineage relationship may have biased the cells 
in the Kolliker’s organ to have a pre-disposition toward the neuronal fate 
particularly in the presence of exogenous Sox2 activity (see Puligilla et al., 2010 
and Raft et al., 2007).  
 
Sox2 has to be down-regulated for neurogenesis to proceed 
         My results indicate that while Ngn1 is sufficient to induce the neurogenic fate, 
commitment to the neuronal fate is somehow blocked in cells over-expressing Sox2, 
despite their high levels of Ngn1 expression. It is possible that the neuronal fate 
cannot progress in Sox2 over-expressed cells because of the high exogenous Sox2 
levels. Ngn1 fails to repress Sox2 in Sox2-over-expressing cells, in which Sox2 is 
driven by an exogenous promoter (β-actin promoter) instead of its endogenous 
promoter.  
         Inhibition of Sox2 transcription is an important molecular step before 
neurogenesis can proceed (Summary Model Fig. 2.13). Both Ngn1 and Neurod1 are 
capable of inhibiting NOP-1 activity and thus presumably down-regulate Sox2 
transcription. The fact that Sox2-overexpressing cells show up-regulation of Ngn1 
but no up-regulation of Neurod1 whereas Ngn1-overexpressing cells do show up-
regulation of Neurod1, suggests that Sox2 needs to be down-regulated before 
Neurod1 expression can be induced. Neurod1 function is an obligatory step for the 
occurrence of neurogenesis. In the mouse hippocampus, the removal of Sox2 from 





Neurod1 (Kuwabara et al., 2009). It is possible that Sox2 negatively regulates 
Neurod1 expression through a similar mechanism in the inner ear, and this negative 
regulation needs to be alleviated by Ngn1 before neurogenesis can proceed. This 
may be the reason for the requirement of down-regulation of Sox2. Once Neurod1 is 
induced, this bHLH protein could further inhibit Sox2 transcription via NOP-1. 
 
Sox2, Ngn1, and Neurod1 form an intrinsic regulatory network within the NSD 
         My results suggest that Sox2, Ngn1, and Neurod1 form an intrinsic regulatory 
network in regulating the NSD. Previous studies have demonstrated that the NSD is 
regulated through extrinsic signaling pathways (Bok et al., 2011; Riccomagno et al., 
2005). Based on my results obtained here it appears that over-expressing Ngn1 or 
Neurod1 can over-ride extrinsic Wnt, Bmp, and retinoic acid activity to promote 
neurogenesis at these early stages of development. Normally, rostro-caudal retinoic 
acid signaling directly regulates the expression of the T-box gene, Tbx1, and the 
anterior/posterior axial specification of the inner ear in a dose-dependent manner 
(Bok et al., 2011). Tbx1 expression is thought to restrict the Ngn1-positive 
neurogenic domain to the anterior otic region (Raft et al., 2004). Signals from the 
hindbrain pattern the dorsal/ventral axis of the otocyst (Bok et al., 2007). Secreted 
Wnt molecules from the dorsal hindbrain induce dorsal-specific otic genes, whereas 
Shh emanating from the ventral hindbrain confers the otocyst its ventral identity 
(Bok et al., 2007). It has been proposed that Wnt together with Bmp signaling from 
the dorsal hindbrain and ectoderm antagonize ventralizing signals such as Shh 





ventral expansion of dorsal otic genes Dlx5/6 and Gbx2, and removal of the dorsal 
hindbrain leads to dorsal expansion of Shh-dependent ventral otic genes Pax2 and 
Ngn1 (Riccomagno et al., 2005). My findings of Ngn1 and Neurod1’s ability to 
induce neurogenesis from all around the ear epithelium suggest that these proteins 
can over-ride the extrinsic inhibitory signaling for neurogenesis outside the NSD, 
and that the entire inner ear is initially competent to be neurogenic. 
 
Sox3 does not play a direct role in regulating neurogenesis 
          A previous publication has demonstrated that Sox3 over-expression leads to 
Sox2 up-regulation in the developing chicken inner ear (Abello et al., 2010). 
Therefore, Sox3 is postulated to be up-stream of Sox2 (Abello et al., 2010). Under 
my experimental conditions, loss of Sox3 function approaches using the EnR(Sox3) 
construct has no apparent effect on neurogenesis as analyzed for Ngn1 expression 
and quantification of CVG sizes. In the Abello et al 2010 study, over-expressing 
Sox3 causes Delta1 to be up-regulated, but there is no ectopic neurogenesis. In these 
experiments, Delta1 is postulated to be up-regulated by Sox3, indirectly through an 
up-regulation of Sox2. This hypothesis is consistent with my findings in chapter 3 
where I show over-expression of Sox2 leads to Delta1 up-regulation. Similar to the 
Abello et al study, I found that over-expressing Sox3 has no apparent change in 
Ngn1 or Neurod1 expression, or the size of the CVG. Taken together, the previous 
publication and my results, I propose that Sox3, though expressed in the NSD, its 





event further down-stream from activation of Sox3 but closely related to activation 
of Sox2.   
 
Sox2 appears to function as a repressor 
        The similarity in the phenotypes elicited by the EnR(Sox2)-GFP construct 
compared to that of Sox2-GFP suggests that Sox2 is functioning as a repressor to 
promote neurogenesis within the inner ear. If Sox2 were acting as an activator, then 
over-expressing VP16(Sox2)-GFP should have yielded the same phenotype for 
Ngn1 expression similar to the Sox2 gain-of-function results. This was not the case. 
In addition, no apparent change in Ngn1 expression within the NSD was obtained 
with the Sox2 activator construct VP16(Sox2)-GFP. This suggests that another 
factor(s) is involved in regulating the NSD. Alternatively, it is possible that there is 
not enough cellular resolution to detect a possible change in Ngn1 expression using 
the in situ hybridization method as this technique is not quantitative. 
        The two constructs, EnR and VP16, are designed to operate with different 
mechanisms. Herpes simplex viral protein 16 (VP16) recruits the transcriptional 
complex including RNA polymerase II and other factors for transcription of the 
target gene, whereas the Engrailed repressor binds to the target gene promoter and 
thereby blocking the transcription machinery from transcribing the target gene. 
However, in this study both VP16 activator or EnR repressor are fused to the HMG 
domain of Sox2. Therefore, the phenotype obtained with either construct should be 
relevant to the function of Sox2. The phenotype obtained with EnR(Sox2) is closer 





obtained with the VP16(Sox2) construct, indicating that Sox2 normally acts as a 
repressor and not an activator with respect toward Ngn1.  
         Both VP16(Sox2) and EnR(Sox2) specimens yielded up-regulation of Ngn1 
expression dorsally, outside the NSD. The reason for this phenotype is unclear, 
especially since neither Sox2 nor Sox3 appear to be normally expressed outside the 
NSD (Uchikawa et al., 1999; Uchikawa et al., 2011). The region dorsal to the NSD 
may be regulated by another intrinsic factor(s) and/or Sox protein(s). The 
EnR(Sox2) and VP16(Sox2) constructs, though appear to be specific for Sox2 in the 
neural tube (see Bylund et al., 2003), may be cross-reacting with binding sites of 
other Sox proteins. Notably, Sox21, which functions as a transcriptional repressor 
for Sox group B1 genes (Sox1-3) in the vertebrate CNS, is expressed broadly in the 
otic cup beyond the NSD (Sandberg et al., 2005; Uchikawa et al., 1999; Uchikawa 
et al., 2011). The function of Sox21, or whether it acts as a repressor or activator in 
the inner ear is not known. One possibility is that Sox21 normally represses Sox2 
expression dorsally and restricts the NSD to the ventral region. As a result, there 
could be a low level of Sox2 or even Sox3, below the level of detection by in situ 
hybridization, in the dorsal otic region. The ectopic up-regulation of Ngn1 in Sox2 
gain-of-function specimens may be due to Sox2 over-riding Sox21’s inhibitory 
effects. Under this scenario, EnR(Sox2) would be mimicking Sox2’s function both 
dorsal and ventrally to up-regulate Ngn1. This up-regulation could be somewhat 
dampened by a weak cross-reactivity of EnR(Sox2) to Sox21 binding sites, which 
could have resulted in inhibition of Sox2 activities. Nevertheless, a net increase of 





was obtained. Furthermore, the cross-reactivity of VP16(Sox2) to Sox21 binding 
sites in the dorsal otic region could alleviate the inhibitory action of Sox21 on Sox2 
and cause an up-regulation of Sox2, thereby up-regulating Ngn1 as well. 
          Sox proteins require the interaction of a binding co-partner that interacts with 
the HMG domain in a cell-context dependent manner (Kamachi et al., 2000; Wilson 
and Koopman, 2002). The binding partner(s) for Sox2 in the inner ear is largely 
unknown. Although, Eya1, which encodes a transcription co-activator has been 
proposed to be a binding partner of Sox2 in the formation of hair cells (Zou et al., 
2008). It is possible that Sox2 selectively partners with a co-activator or co-
repressor in a cell-context dependent manner within the inner ear, and the two 
constructs EnR(Sox2) and VP16(Sox2) could be behaving differently in ventral 
versus dorsal otic regions. Based on my Sox2 gain and loss-of-function approaches, 
my working hypothesis is that Sox2 normally acts as a repressor in the NSD and its 
activity leads to inhibition of an inhibitor of Ngn1, thereby leading to the induction 
of neurogenesis by up-regulation of Ngn1. 
 
Sox2’s role in the sensory fate 
              Sox2 is expressed in the NSD, but its expression is down-regulated in 
delaminating neuroblasts. The expression of Sox2 persists in the sensory lineage 
until hair cells start to differentiate (Dabdoub et al., 2008; Neves et al., 2007). In 
humans, mutations in SOX2 lead to senorineural hearing loss, and mice without 
Sox2 are deaf (Hagstrom et al., 2005; Kiernan et al., 2005). In wildtype mice, the 





transcription factor Atoh1 (Dabdoub et al., 2008). Forced expression of Atoh1 in a 
P-19 cell line leads to down-regulation of endogenous Sox2 expression, suggesting 
that Atoh1 counteracts Sox2 activity, whereas over-expression of Sox2 in mouse 
cochlear explants leads to loss of hair cell formation and up-regulation of a pro-
sensory gene, Prox1 (Dabdoub et al., 2008). These findings are in agreement with 
the notion that there is a requirement for Sox2 to be down-regulated for hair cell 
differentiation similar to the earlier requirement for Sox2 to be down-regulated for 
neuronal differentiation as demonstrated here. Forced expression of Sox2 in the 
NSD leads to a decrease in neurogenesis. It will be interesting to determine the 
consequence of these heightened Sox2 levels on the sensory lineage. My prediction 
is that forced Sox2 expression will lead to an expansion or ectopic formation of 
sensory domains and possibly an increase in hair cell formation. Alternatively, if 
Sox2 levels remain high in the sensory domains, it could inhibit subsequent hair cell 
formation. In chapter 3 of this dissertation, I demonstrate the potential interaction of 
Sox2 and the Notch signaling pathway in mediating neuronal and sensory cell fate 
choices, and my results indicate that Sox2 plays a non-cell-autonomous role in 
regulating neurogenesis and specifying the sensory fate, in addition to its cell-
autonomous role in neurogenesis described here. 
 
Conclusion 
          I have found an important molecular mechanism of regulation of the NSD by 
Sox2. I have demonstrated that Sox2 and Ngn1 play pivotal roles in regulating 





network within the NSD. A tight temporal regulation of the levels of Sox2 is critical 
for neurogenesis to proceed normally. While Sox2 is capable of inducing Ngn1 in 
the developing inner ear, it is unlikely to be the only factor involved in this process. 
The proposed repressor role of Sox2 in inducing Ngn1 also requires further 
investigation. Nevertheless, it will be interesting to investigate whether Sox2 utilizes 
similar molecular mechanisms in the formation of other cranial placodes and 















Chapter 3: Sox2 and the Notch signaling pathway interact 
to regulate neuronal and sensory cell fate choices in the 
developing inner ear  
Introduction 
Notch signaling regulates neurogenesis via lateral inhibition  
            Notch is a trans-membrane receptor and its known ligands in chicken are 
Delta1, Serrate1 (Ser1), and Serrate2 (Ser2) (equivalent to Jagged1 and Jagged2 in 
mouse, respectively).  There are four known vertebrate Notch receptors and so far 
only Notch1 has been shown to be expressed in the inner ear (Lewis et al., 1999). In 
vertebrate inner ears Notch signaling mediates cell fate choices between neuronal 
and sensory cells during neurogenesis and between sensory hair cells and supporting 
cells within the sensory lineage. The mechanisms for these cell fate choices are 
similar to mechanosensory bristles formation in Drosophila (Adam et al., 1998). 
Notch1, Ser1, and Delta1 are expressed in the NSD of the developing chicken inner 
ear (Adam et al., 1998; Cole et al., 2000). The expression domain of Notch1 is broad 
in the ear rudiment and encompasses more than the presumed NSD (Adam et al., 
1998; Shailam et al., 1999). Ser1 is involved in formation of the pro-sensory patch 
in the chicken inner ear, and Delta1-Notch signaling mediates cell fate choices 
between neuronal and sensory cells through lateral inhibition (Daudet et al., 2007). 
Delta1 is expressed in cells destined to become neuronal and it induces a sensory 
fate in neighboring cells via the Notch receptor (Bertrand et al., 2002; Daudet et al., 





cleavage of the intracellular domain of Notch by the enzyme γ-secretase. The 
intracellular domain (Notch-ICD) then translocates into the nucleus to activate Hes 
and Hey genes, which are negative regulators of pro-neural bHLH genes such as 
Ngn1 (Bertrand et al., 2002; Cau et al., 2000). When Notch signaling is blocked 
with a γ-secretase inhibitor, DAPT, expression of Delta1 and neurogenesis initially 
increase because lateral inhibition is alleviated, and Hes5.1 expression (chicken 
homolog of mammalian Hes5) is down-regulated presumably consequently in 
adjacent cells (Daudet et al., 2007). The similar lateral inhibition process is thought 
to mediate hair cell and supporting cell fates within the sensory patch via ligands 
such as Delta1, Jag1, and Jag2 (Brooker et al., 2006; Hartman et al., 2010; Kiernan 
et al., 2001; Kiernan et al., 2005; Lanford et al., 1999; Pan et al., 2010; Tsai et al., 
2001; Zhang et al., 2000).  
 
Known interactions between Sox2 and the Notch signaling pathway 
              Notch signaling has been proposed to act up-stream as well as down-stream 
of Sox2. Jag1/Ser1 mediated Notch signaling has been proposed to induce Sox2 
expression in mouse cochlear explant cultures and chicken otic cup (Dabdoub et al., 
2008; Daudet et al., 2007). Consistently, Jag1 conditional knockout mouse mutants 
show down-regulated Sox2 expression, whereas in lcc mutants, which has no Sox2 
expression in the inner ear, Jag1 expression is not affected (Dabdoub et al., 2008; 
Pan et al., 2010). These results suggest that the Notch signaling pathway is up-
stream of Sox2. Nevertheless, studies in the mouse retina suggest that Notch could 





promoter was found in vitro, even though it is not clear whether this binding is 
biologically relevant (Taranova et al., 2006). In mouse neocortical cultures, over-
expression of Sox2 leads to up-regulation of Notch1 and Hes5 transcripts, and to 
decreased neurogenesis (Bani-Yaghoub et al., 2006). Additionally, over-expressed 
Notch-ICD mouse mutants show ectopic sensory patches with the up-regulation of 
both Jag1 and Sox2 (Hartman et al., 2010; Pan et al., 2010). More recent studies in 
the chicken inner ear suggest that Jag1 cannot induce Sox2, but is required to 
maintain its expression (Neves et al., 2011). Taken together, these studies suggest 
that Sox2 and Notch signaling are interacting closely to mediate cell fate choices.  
 
              In chapter 2 of this dissertation, I have demonstrated that Sox2 plays a cell-
autonomous role in regulating neurogenesis. In this chapter, I address the potential 
interactions of Sox2 and the Notch signaling pathway in mediating neuronal and 
sensory cell fate choices. I show that over-expressing Ngn1 leads to a subsequent 
expansion of the Sox2 domain after Ngn1-postive cells have left the ear epithelium. 
Over-expressing the intracellular domain of Notch (NICD) leads to an expansion of 
the Sox2 domain. Over-expressing Ngn1 is sufficient to up-regulate Delta1, and 
over-expressing Sox2 leads to up-regulation of Delta1 and Hes5.1. These findings 
suggest that Notch signaling is up-stream of Sox2, and that Sox2 plays a cell-








Materials and Methods 
Eggs, in ovo Electroporation, and Expression Constructs 
Fertilized chicken eggs (B&E York Springs, PA) were incubated at 37° C 
and staged according to Hamburger and Hamilton (Hamburger and Hamilton, 
1992). Full-length cDNA of mouse Ngn1were subcloned into the pMES-IRES-GFP 
expression vector (GFP), in which various cDNA is driven by a chicken β-actin 
promoter (Ngn1-GFP). The Notch intracellular domain NICD was subcloned into 
the pCAB-IRES-GFP vector (NICD-GFP). The internal ribosomal entry site (IRES) 
mediates bicistronic expression of the Green Fluorescent protein. The plasmids were 
delivered to the right otic cup between 10-17 somite stages (E1.5) by 
electroporation.  This was conducted by filling the right otic cup with plasmids at a 
concentration of 3-4 µg/µl in 0.1% Fast Green. Then, a negative platinum electrode 
was placed above the right otic cup and the positive electrode inserted underneath 
the embryo at the location of the left otic cup. Two pulses at 7 volts with 100 msec 
duration and spacing were applied using a CUY21 electroporator. After 
electroporation, the eggs were sealed and returned to the incubator and harvested 
between 20 to 48 hrs.  
 
In situ hybridization 
              Tissue-section in situ hybridization was carried out as previously described 
(Raft et al., 2007; Wu and Oh, 1996). Chicken Dig-labeled anti-sense RNA probes 







              Cryo-sections were prepared as described above for in situ hybridization. 
The primary antibodies used were rabbit polyclonal anti-Sox2 (1:4000 Chemicon), 
and goat polyclonal anti-GFP-FITC-conjugated (1:400 GeneTex). The secondary 
antibody was goat anti-rabbit Alexa Fluor 568 (1:250 Invitrogen). Antibody labeling 
was performed according to standard protocol (Raft et al., 2007), except the sections 
for labeling with anti-Sox2 were first subjected to citrate boiling for 5 min for 
antigen retrieval prior to immunostaining.  
 
Results 
Over-expressing Ngn1 leads to a subsequent expansion of the Sox2 domain 
              In chapter 2, I have demonstrated the initial down-regulation of Sox2 in 
Ngn1 treated ears within 15 hrs of electroporation (see Fig.2.4). Despite this down-
regulation, the Sox2-positive domain was expanded by 45 hrs (Fig.3.1). Double-
labeling with anti-Sox2 and anti-GFP antibodies indicate that while Sox2 is 
expressed in the NSD of GFP control ears (Fig.3.1 c’), the Sox2-positive domain in 
Ngn1-GFP ears is expanded anterior-dorsally beyond the NSD (Fig.3.1 e’). These 
Sox2-positive cells are GFP-negative, and most GFP-positive cells are outside of the 
otic epithelium where GFP-positive neuroblasts have delaminated from an earlier 
time (Fig.3.1 f, red asterisk). Furthermore, in control as well as the Ngn1-GFP 
treated ear, the delaminated neuroblasts show down-regulated Sox2 expression 
(Fig.3.1 white asterisks). This is consistent with findings in the central nervous 





observation in the inner ear (see Fig.2.1) that Sox2 expression is down-regulated in 
differentiating neuroblasts. The finding that there is a secondary up-regulation of 
Sox2 expression in the otic epithelium after neuroblast delamination suggests that 
over-expressing Ngn1 has a non-cell-autonomous effect on Sox2 expression, which 
could be mediated by the Notch signaling pathway. 
 
                                                           Figure 3.1 
 
Figure 3.1. Over-expressing Ngn1 leads to an expansion of the Sox2 domain. 
Sections of GFP control and Ngn1-GFP treated ears double-labeled with anti-Sox2 
and anti-GFP antibodies 45 hrs after electroporation. Sox2 expression in the GFP 
control ear is in the NSD (c’) and not in regions outside the NSD (b’) or the 
delaminated neuroblasts (c’, asterisk; n=3). GFP-positive cells can be found within 
the NSD domain and the CVG (c, asterisk). Ngn1-GFP-treated specimens show 
expanded Sox2 staining (e’ between white arrowheads) dorsally beyond the NSD (f’ 





negative (f), whereas large numbers of GFP-positive cells are in the ganglion, which 
are Sox2 negative  (f’ asterisk).  Levels of sections are indicated in the wholemounts 
(a, d; white lines). The outline of the otocyst is indicated in red (a, d). Ear epithelia 
are outlined in white (b-c’, e-f’). 
 
Over-expressing the intracellular domain of Notch (NICD) leads to up-
regulation of Sox2 
            To investigate whether Notch signaling could be involved in the secondary 
up-regulation of Sox2 in Ngn1 over-expressed specimens, I first over-expressed 
NICD-IRES-GFP at otic cup stages by electroporating and analyzed Sox2 
expression at 20 hrs later. Normally, Notch1 is expressed broadly in the inner ear 
dorsally and ventrally (data not shown, see (Adam et al., 1998; Lewis et al., 1999; 
and Shailam et al., 1999)). In the NICD-treated ear, where Notch signaling is 
constitutively active, the Sox2 expression domain is expanded dorsally in addition to 
its normal expression in the NSD compared to control (Fig.3.2). These results show 
that constitutively activated Notch signaling is sufficient to up-regulate Sox2. 
 
                                                           









                                                             Figure 3.2 
 
Figure 3.2 Over-expressing NICD is sufficient to up-regulate Sox2. Otic cups 
electroporated with GFP control or Sox2-GFP at 20 hr harvest (a, c; inset). Ears are 
outlined in red and the level of sectioning is indicated with white lines (a, c; insets). 
Adjacent sections probed for GFP and Sox2 transcripts (a-d). Sox2 expression is 
restricted to the NSD of controls (b red bracket, n=2), whereas its expression in 
NICD-treated ears is within (d, red bracket) as well as beyond (d, yellow bracket; 








Over-expressing Ngn1 leads to ectopic Delta1 up-regulation 
            Taken together the above results suggest that the secondary, non-cell-
autonomous up-regulation of Sox2 in Ngn1 over-expressed specimens could be 
mediated through the Notch signaling pathway. If so, what might be the Notch 
ligand(s) responsible for activating the Notch receptors? Delta1 is a likely candidate 
since Delta1 is expressed in neuroblasts within the NSD (Adam et al., 1998), and 
this ligand has been proposed to mediate lateral inhibition of the neuronal fate 
(Daudet et al., 2007). Additionally, forced expression of Ngn1 in Xenopus leads to 
ectopic up-regulation of Delta1 (Ma et al., 1996). To analyze if a similar 
relationship occurs in the inner ear, Ngn1-treated ears were probed for Delta1 
transcripts 20 hrs after electroporation (Fig. 3.3). Normally, Delta1 expression is 
restricted to the NSD (Fig.3.3b-e), whereas in the Ngn1-treated ear, Delta1 
expression is ectopically expressed outside of the NSD (Fig.3.3g-j). These results 
show that Ngn1 is sufficient to up-regulate Delta1 expression in my experimental 
conditions and suggests that Delta1 is the main ligand for activating Notch signaling 
in neighboring cells, which leads to up-regulation of Sox2 expression. 
 










                                               Figure 3.3 
 
Figure 3.3 Over-expressing Ngn1 leads to ectopic up-regulation of Delta1. Otic 
cups over-expressed with GFP (a) or Ngn1-GFP (f) at 20 hrs after electroporation. 
The ears are outlined in red and levels of sectioning are indicated in white lines. 
Adjacent sections probed for GFP and Delta1 transcripts (b-e, g-j). GFP control 
shows Delta1 expression in the NSD domain only (e, n=2), and not in dorsal GFP-
positive regions (c). Ngn1-GFP specimens show ectopic Delta1 expression dorsally 
(h) and ventrally (j), which overlaps with the GFP domain (g, i; n=3/3). 
 
Over-expressing Sox2 leads to ectopic Delta1 and Hes5.1 up-regulation 
In chapter 2, I have demonstrated that over-expression of Sox2 leads to cell-
autonomous Ngn1 up-regulation (see Fig.2.2 and Fig.2.3). Yet, this up-regulated 
Ngn1 is insufficient to drive neurogenesis. Here, Ngn1 over-expression leads to 





could be occurring in Sox2-over-expressed specimens. This prompted me to analyze 
expression patterns of Delta1 in Sox2 over-expressed ears. Figure 3.4 illustrates that 
Delta1 expression is up-regulated ectopically in Sox2-treated ears (Fig.3.4a-d). To 
investigate whether this Delta1 up-regulation actually resulted in activating the 
Notch signaling pathway, I investigated the expression pattern of Hes5.1, which is a 
gene down-stream of Notch signaling. Indeed, Hes5.1 is ectopically up-regulated 
outside the NSD in Sox2-treated ears compared to control (Fig.3.4e-h). These results 
suggest that there is heightened Notch signaling in Sox2-over-expressed specimens 
and a possible non-cell-autonomous inhibition of the neuronal fate. 
 
            Figure 3.4 
 
Figure 3.4 Over-expressing Sox2 leads to ectopic up-regulation of Delta1 and 
Hes5.1. Otic cups electroporated with GFP and Sox2-GFP at 20 hr harvests (a, c, e, 





white lines (a, e, c, g; insets). Adjacent sections probed for GFP, Delta1, and Hes5.1 
transcripts (a-d and e-h). Delta1 (d, n=4/4) and Hes5.1 (h, n=4/4) are expressed 
within the NSD (d and h; red brackets) but are also up-regulated outside the NSD (d 
and h; yellow brackets) of Sox2-treated ears compared to controls (b, n=3; and f, 
n=4), which have expression only in the NSD (b and f; red brackets).  
 
Discussion and Future Studies 
Over-expressing Sox2 causes non-cell-autonomous inhibition of the neuronal 
fate via Notch-activated lateral inhibition        
           The reason for the phenotype of ectopic Ngn1 up-regulation but no ectopic 
neurogenesis obtained in chapter 2 when Sox2 is over-expressed is two-fold. One, 
Ngn1 can’t inhibit Sox2 transcription of the exogenous construct. Two, Delta1 is up-
regulated in Sox2 over-expressed cells through the up-regulation of Ngn1, and 
directly by Sox2, leading to activation of the Notch signaling pathway and thereby 
lateral inhibition of the neuronal fate in adjacent cells. Up-regulation of Delta1 in 
Sox2 over-expressed cells further suggests that these cells are going down the 
neuronal lineage. Furthermore, activated NICD leading to up-regulation of Sox2 
seems to be one cause of the expanded Sox2 domain in Ngn1 over-expressed 
specimens, suggesting that cells adjacent to once Ngn1-positive cells are 
presumably going down the sensory lineage. Therefore, over-expressing Sox2 






The neural-sensory competent domain appears to be broader than commonly 
thought 
           The fact that Sox2, Ngn1, and NICD all seem to induce the neuronal/neural-
sensory competent fate dorsally suggests that the NSD is broader than commonly 
thought and includes the dorsal region. Delta and Serrate ligands are normally not 
expressed in the dorsal region, but Notch1 is (Adam et al., 1998; Cole et al., 2000; 
Lewis et al., 1999; Shailam et al., 1999). Some extrinsic factors like Wnt signaling 
could be inhibiting the expression of these ligands in the dorsal region. Wnt 
signaling is known to restrict the Ngn1-positive NSD ventrally (Riccomagno et al., 
2005). Taking all the results into consideration, it appears that Sox2, Ngn1, and 
NICD are capable of over-riding Wnt activity in the dorsal domain. 
 
Sox2 has a cell-autonomous and non-cell-autonomous role in regulating 
neuronal and sensory fates 
In addition to the cell-autonomous up-regulation of Ngn1 in Sox2 over-
expressed ears shown in chapter 2, the up-regulation of Delta1 by Ngn1 and the up-
regulation of Delta1 and Hes5.1 by Sox2 suggest possible cell-autonomous and non-
cell-autonomous relationships between these genes and the Notch signaling pathway. 
Previous studies indicate that Delta1 is expressed in pro-neural progenitors similar to 
Ngn1, and Hes5.1, a negative regulator of Ngn1, is expressed in non-neuronal 
progenitors (Cau et al., 2000; Daudet et al., 2007). It remains to be demonstrated that 
the up-regulations of Delta1 by Ngn1 and Sox2 is cell-autonomous, whereas the up-





using immunohistochemical techniques. Dr. Ram Mishra in our laboratory has 
generated rabbit polyclonal antibodies against Delta1 and Hes5.1 and these antibodies 
are currently being characterized. I would expect the double-antibody labeling 
experiments to confirm that Delta1 is up-regulated cell-autonomously by Ngn1 and 
Sox2, and that Hes5.1 is up-regulated in adjacent cells that over-express Sox2 or 
Ngn1. 
To demonstrate that Sox2 interacts non-cell-autonomously with the Notch 
signaling pathway in regulating neurogenesis, I recommend that further studies are 
performed by inhibiting the Notch signaling pathway concomitantly with over-
expressing Sox2 (see Working Models Fig.3.5 below). This could be accomplished by 
using a γ-secretase inhibitor DAPT (N-[(3,5-Difluorophenyl)acetyl]-L-al anyl-2-
phenyl]glycine-1,1-dimethylethyl ester), which blocks the Notch intracellular domain 
NICD from being cleaved and translocated into the nucleus to up-regulate a set of 
genes including Hes5.1. The use of DAPT should be followed immediately by 
electroporating with Sox2-GFP. In my pilot studies, I have begun to optimize the 
method and narrowed the concentration of optimal DAPT use in vivo to 5mM in 
100% DMSO, as some specimens show down-regulation of Hes5.1 at this 
concentration (n=2/3, data not shown). I would predict that Sox2 expression will be 
down-regulated by DAPT alone treatments because Notch signaling is postulated to 
be up-stream of Sox2 and neurogenesis will be increased because lateral inhibition 
mediated by Notch signaling will be impaired. Alternatively, no changes in Sox2 
expression may be obtained in DAPT alone treatments because Sox3 is postulated to 





when Notch is blocked by DAPT. Over-expressing Sox2-GFP in the presence of 
DAPT will test if exogenous Sox2 mediates parts of its effects on neurogenesis via 
Notch signaling. I would expect an improvement in neurogenesis compared to over-
expressing Sox2-GFP without DAPT treatment. This prediction is based on the 
assumption that blocking Notch signaling will alleviate the non-cell-autonomous 
effects resulting from over-expression of Sox2. 
                                                             












Figure 3.5 Working models of Sox2 function in Sox2 over-expressed cells, DAPT 
treatment, and Sox2 over-expression + DAPT treatment. Sox2 over-expression 
has cell-autonomous and non-cell-autonomous effects between cells A and B in 
regulating neuronal and sensory cell fates.  
When Sox2-GFP is over-expressed in cell A, Sox2 up-regulates Ngn1 in cell 
A, but Ngn1 in turn can’t block Sox2 promoter activity in order for Neurod1 to be up-
regulated and neurogenesis to proceed. Therefore cell A cannot be committed to the 
neuronal fate because exogenous Sox2 cannot be down-regulated. This is the cell-
autonomous effect of Sox2 over-expression in inhibiting neurogenesis. At the same 
time Ngn1 is up-regulated, Delta1 is also up-regulated in cell A. Delta1 activates 
Notch receptors in cell B. As a result, Notch is cleaved by γ-secretase, and the 
activated Notch (Notch-ICD) translocates to the nucleus to activate target genes such 
as Hes5.1 and Sox2 in cell B. Hes5.1 in turn blocks Ngn1 and therefore Delta1 
expression in cell B. Consequently, cell B goes on to become a sensory cell. In 
contrast, if Sox2-GFP is over-expressed in cell B (not illustrated), the fate of cell B 
may not necessarily change, but the expected up-regulation of Delta1 in cell B will 
block the neuronal fate in cell A. This is the non-cell-autonomous effect of Sox2 over-
expression in inhibiting neurogenesis.  
          Application of the chemical compound DAPT blocks the Notch signaling 
pathway by blocking γ-secretase. This will test the involvement of the Notch 
signaling pathway in mediating neurogenesis and whether Notch signaling normally 
functions up-stream of Sox2. Sox2 expression should be down-regulated by DAPT 





neurogenesis will be increased because lateral inhibition mediated by Notch will be 
impaired. Alternatively, no changes in Sox2 expression may be obtained since Sox3 is 
also postulated to be up-stream of Sox2, thereby Sox3 could be compensating for the 
loss of Sox2 expression when Notch is blocked by DAPT treatment.  
          Over-expressing Sox2-GFP in the presence of DAPT will test if Sox2 
mediates parts of its functions via Notch signaling. An improvement in neurogenesis 
should be obtained because blocking Notch signaling would block non-cell-















Chapter 4: Summary and Conclusions 
Summary and Conclusions 
           This dissertation investigates the roles of Sox2 and Sox3 in inner ear 
development using gain and loss-of-function approaches in the developing chicken 
inner ear. My results show that Sox2 plays a major role during neurogenesis, 
whereas Sox3’s role in neurogenesis seems to be indirect, mediated through 
regulation of Sox2. In chapter 2, I demonstrate that Sox2 and Neurogenin 1 regulate 
the neurogenic fate and in chapter 3, I address the potential interactions between 
Sox2 and the Notch signaling pathway in mediating neuronal and sensory cell fate 
choices. My results from chapter 2 indicate that over-expressing Sox2 in the otic cup 
stage leads to up-regulation of Ngn1 but no induction of Neurod1 or subsequent 
increase in neurogenesis. In contrast, up-regulation of Ngn1 alone is sufficient to 
induce Neurod1 and increase neurogenesis. These results indicate that while Ngn1 is 
sufficient to induce the neurogenic fate, yet commitment to the neuronal fate is 
somehow blocked in cells over-expressing Sox2, despite their high levels of Ngn1 
expression. Normally, Sox2 is down-regulated in the neuronal lineage. In Ngn1- 
over-expressing cells, Sox2 expression is down-regulated within 15 hrs. Therefore, 
it is possible that the neural fate cannot progress in Sox2-over-expressed cells 
because of the high exogenous Sox2 levels. Given the role of Ngn1 in inhibiting 
Sox2 and Sox3 in the neural tube, I interpret my results to indicate a requirement for 
a transcriptional repression of Sox2 activity in order for neurogenesis to proceed. 
This repression could be normally mediated by Ngn1, which fails to repress 





Sox2 and perhaps some other unknown factor(s) normally initiate neurogenesis by 
up-regulating Ngn1, Sox2 needs to be down-regulated by Ngn1 in order for 
neurogenesis to progress.  The fact that Ngn1 counteracts NOP-1 activity suggests 
that Ngn1 counteracts Sox2 activity directly possibly by interacting with an E-
protein at the E-box motif within the NOP-1 enhancer of the Sox2 promoter. 
Inhibition of Sox2 transcription appears to be an important step before Neurod1 can 
be activated and neurogenesis to proceed, since Neurod1 is up-regulated in Ngn1- 
but not Sox2-over-expressed cells. Interestingly, Neurod1 is also able to inhibit the 
enhancer activities of NOP-1. Therefore, it is likely that once Neurod1 expression is 
activated normally, Sox2 expression in the neuronal lineage is further reduced.  
            In chapter 3, I have demonstrated a potential interaction of Sox2 and the 
Notch signaling pathway in mediating neuronal and sensory cell fate choices. I 
show that there is a secondary effect on Sox2 expression after Ngn1-positive cells 
have delaminated from the ear epithelium. Although Sox2 is initially down-
regulated in Ngn1-treated ears, it is subsequently up-regulated presumably in 
adjacent cells to once Ngn1-positive cells; i.e. the Sox2 domain is expanded 
dorsally. This suggests a non-cell-autonomous effect on Sox2 expression possibly 
through activation of the intracellular domain of the Notch receptor (NICD). In my 
hands, over-expressing NICD leads to an expansion of the Sox2 domain. Members 
of the Notch signaling pathway, the expression of the ligand Delta1 and the 
transcriptional repressor Hes5.1 are up-regulated in Sox2-over-expressed ears, and 
Delta1 is up-regulated in Ngn1-over-expressed ears. I take my findings to indicate 





autonomously in regulating the NSD. I propose that over-expression of Sox2 leads 
to up-regulation of Delta1, which activates Notch receptors in adjacent cells to 
inhibit neurogenic fate possibly by up-regulating Hes5.1 and Sox2. Both Sox2 and 
Ngn1 are able to up-regulate Delta1. Hes5.1 is up-regulated by Sox2 and predicted 
to be up-regulated by Ngn1 via Delta1 up-regulation in presumably adjacent cells. 
Delta1-expressing cells adopt a neuronal fate, whereas Hes5.1 and Sox2 expression 
in adjacent cells presumably leads them to adopt a sensory fate. Future studies will 
have to be performed to demonstrate the cell-autonomous and non-cell-autonomous 
relationships, possibly by using a double-antibody labeling approach and by over-
expressing Sox2 via electroporation concomitantly with inhibiting the Notch 
signaling pathway through DAPT treatment.  
          The fact that Sox2, Ngn1, NICD all induce the neuronal/neural-sensory 
competent fate dorsally suggests that the NSD is broader than commonly thought 
and includes the dorsal region. The limiting factor is that Notch ligands such as 
Delta and Serrate are normally not expressed in the dorsal area, whereas Notch1 is. 
It is very likely that extrinsic signaling pathways such as Wnt signaling regulate this 
dorsal area and prevent the expression of these ligands, as Wnt signaling is known 
to restrict the Ngn1-positive NSD ventrally. 
 
 







                                                           Figure 4.1 
 
Figure 4.1. Summary Model.  
Sox3 and Notch are up-stream of Sox2, and Sox2 and the Notch signaling pathway 
regulate neuronal and sensory cell fate choices cell-autonomously and non-cell-
autonomously. In cell A Sox2 up-regulates Ngn1. Ngn1 in turn blocks Sox2 promoter 
activity in order for Neurod1 to be up-regulated and neurogenesis to proceed. 
Therefore, cell A becomes neuronal. At the same time, Delta1 is up-regulated in cell 
A. Delta1 activates Notch receptors in cell B. As a result, Notch is cleaved by γ-
secretase, and the activated Notch (Notch-ICD) translocates to the nucleus to activate 
target genes such as Hes5.1 and Sox2 in cell B. Hes5.1 in turn blocks Ngn1 and 
therefore Delta1 expression in cell B. Consequently, cell B goes on to become a 







Loss of Sox2 function 
 Although I have extensively tried to test Sox2 loss-of-function in this study, 
the experiments yielded a mixed phenotype for the expression of Ngn1 (see chapter 
2). I recommend that future studies are performed with alternative methods to using 
the dominant negative repressor Engrailed construct. For instance, use of 
morpholinos or inhibitory RNA’s (RNA interference (RNAi)) could proof more 
conclusive. These methods knock down gene function itself as opposed to interfering 
with down-stream target genes as in the case of the dominant negative repressor, and 
the oligos can be easily obtained and electroporated with the method I have 
developed. However, in my hands experiments with and analyses of two independent 
translation-blocking morpholinos to Sox2 has so far not yielded successful knock-
down of Sox2 (data not shown).  
 
Sox2 and the Notch signaling pathway 
 The cell-autonomous and non-cell-autonomous relationships between Sox2 
and the Notch signaling pathway remain yet to be demonstrated (see chapter 3 
discussion). I recommend the use of antibodies against Delta1 and Hes5.1 as well as 
blocking Notch signaling concomitantly with over-expressing Sox2 to be performed 








Sox2’s role in the sensory lineage 
 Although I demonstrate that Sox2 and the Notch signaling pathway potentially 
interact in mediating neuronal and sensory cell fate choices, this dissertation 
investigates the role of Sox2 during neurogenesis and not the hair cell fate per se. 
However, my findings in chapter 3 suggest that Sox2 plays a role in sensory fate 
specification after Ngn1-postive cells have left the NSD epithelium. It would be 
interesting to see what happens to the hair cell fate if Sox2 over-expressed ears are 
incubated past 48 hrs and analyzed for sensory and hair cell markers at 72 hr harvests. 
My hypothesis is that forced Sox2 expression will lead to an expansion or ectopic 
formation of sensory domains and possibly to increased formation of hair cells. 
Alternatively, forced expression of Sox2 in the NSD may lead to a decrease in hair 




Why is Sox2 in inner ear development important? 
            The website of the National Institute on Deafness and Other Communication 
Disorders states that approximately 36 million Americans suffer from some form of 
hearing loss (http://www.nidcd.nih.gov/). The majority of the cases is due to 
sensorineural hearing loss caused by mutations, aging, certain tumors, infections, 
ototoxic drugs, or loud sound exposures. Depending on the situation, damages can 
be occurring at the level of sensory hair cells or neurons of the spiral ganglion, or 





cochlear implants. My study is not only important from the point of view of 
development but also for therapeutic approaches in combating hearing disorders. 
The findings in this study will provide a greater understanding of the molecular 
mechanisms involved in regulating neuronal and sensory fates and may provide 
better strategies for gene therapy in replacing damaged neurons or sensory hair 
cells.  
  Adult mammalian cochlear hair cells are not able to regenerate, although 
hair cells in the vestibular system are able to regenerate to some extent, whereas 
avian, fish, and amphibian hair cells are able to regenerate throughout life (Cotanche 
and Kaiser, 2010; Staecker and Van De Water, 1998). The mammalian cochlea 
consists of a mosaic and precise pattern of hair and supporting cells. There are three 
known possible mechanisms of hair cell renewal: regenerative proliferation of 
supporting cells (e.g. re-entering the cell cycle), trans-differentiation of supporting 
cells into hair cells, and repair of damaged hair cells (e.g. migration of macrophages 
to location of damaged hair cell) (Staecker and Van De Water, 1998). Miss-
expression of the Atoh1 gene in the guinea pig and mouse ear leads to trans-
differentiation of supporting cells into hair cells, and pharmacological inhibition of 
the Notch signaling pathway in the organ of Corti leads to supernumary hair cells 
from supporting cells (Brigande and Heller, 2009). Furthermore, inhibiting cell 
cycle inhibitors such as p27Kip1 allows supporting cells to re-enter the cell cycle 






             Manipulating stem cells in vitro by providing appropriate guidance signals 
and re-introducing them in vivo allows for the differentiation of a selective cell 
lineage such as hair cells or neurons. Supporting cells have been identified to be one 
source of potential stem cells/progenitor cells for hair cell replacement, the other 
sources being embryonic and induced pluripotent stem cells (Oshima et al., 2010; 
Smeti et al., 2011; White et al., 2006). Sox2 and the Notch ligand Jag1 are 
expressed in supporting cells of the post-natal organ of Corti, but their expression 
gradually declines in the adult (Smeti et al., 2011). Sox2 and Jag1 are considered 
pro-sensory genes and Jag1 is later involved during lateral inhibition of the hair cell 
fate (see chapters 1 and 3). Sox2 and Atoh1 have been demonstrated to interact in 
regulation of the hair cell fate (Dabdoub et al., 2008). Given the nature of Sox2 and 
Jag1 function in hair and supporting cell development, the temporal expression 
patterns of these genes may provide windows of opportunities for therapeutic 
interventions in hair cell regeneration from supporting cells. Furthermore, given 
Sox2’s role as a key player in embryonic and induced pluripotent stem cells, it is 
actively being used for studies in regeneration of hair cells from stem cells ((Oshima 
et al., 2010) also see chapter 1). Current approaches for regenerating neurons of the 
inner ear also use stem cell methodology with the involvement of Sox2 and the 
Notch signaling pathway. For instance, blocking Notch signaling in neurospheres 
generated from mouse utricular stem cells increases hair cell production at the 
expense of supporting cells and neurons, whereas forced expression of the Notch 
intracellular domain NICD leads to up-regulation of Ngn1 indirectly through the up-





regulated by a target of NICD, RBP-J, since a binding site for RBP-J has been 
identified in vitro within the Ngn1 promoter (Jeon et al., 2011). This dissertation 
identifies an important molecular mechanism of Sox2 function in the regulation of 
the neuronal fate and makes strong implications for an interaction of Sox2 with the 
Notch signaling pathway in mediating neuronal and sensory cell fate choices. 
Although it does not deal with the hair cell fate per se, findings in this study could 
prove instrumental for future studies in combating hearing disorders and for both 






























        Appendix 
 
Generation of Lunatic fringe Cre-ERT2 mice for fate-
mapping sensory domains of the inner ear 
 
Introduction 
Lunatic fringe is expressed in the neural-sensory competent region of the otic 
vesicle and in all subsequently derived sensory organs  
 
The vertebrate inner ear, which is made up of a labyrinth of sensory and non-
sensory components, develops from a simple tear-drop shaped vesicle. The antero-
ventral region of the otic vesicle is the presumed neural-sensory competent region. In 
mammals, this region gives rise to neurons of the auditory and vestibular ganglia, and 
to six sensory organs including three cristae, the utricle and saccule, and the organ of 
Corti. The precise region of the neural-sensory competent region within the ear 
rudiment is not clear and is thought to be marked by the expression of a number of 
genes such as Lunatic fringe (Lfng) and Neurogenin 1 (Ngn1). Lfng is an extracellular 
modulator of the Notch signaling pathway (Irvine, 1999), whereas Ngn1 is a bHLH 
(basic-Helix-Loop-Helix) transcription factor. Ngn1 specifies the neuronal fate and is 
expressed in neuronal progenitors. Genetic fate mapping studies of the neurogenic 
domain using Ngn1-CreER mice show that Ngn1-positive cells give rise to the 
neurons of the auditory and vestibular ganglia as well as sensory cells in the utricular 





not clear which areas of the neural-sensory competent domain give rise to the three 
cristae and the organ of Corti. Since Lfng is expressed in all sensory organs and its 
expression domain at the otic vesicle stage encompasses and is broader than that of 
Ngn1 domain, I sought to fate map the neural-sensory competent region of the inner 
ear by generating Lfng-creERT2 mice, in which a tamoxifen-inducible cre 
recombinase (Cre-ERT2) is knocked into the Lfng genomic locus. Fate mapping the 
progenies of Lfng-positive cells could provide a more complete picture of the neural-
sensory competent region and insights into how individual sensory organs arise from 
a common domain.  
 
Materials and Method 









I replaced Exon1 of the genomic Lfng locus with a Cre-ERT2-neo cassette using 
homologous recombination via the bacterial artificial chromosome (BAC) 
recombineering technique. The construct was electroporated into embryonic stem 
cells (ES) strain 129 by the company Xenogen. I identified positive ES clones 
through Long Range PCR and confirmed by Southern blot. The mice were generated 
by Xenogen. I confirmed the genotypes of the mice using Southern blots. 
 
Induction of Cre activity requires tamoxifen 
 
The cre recombinase is fused to a synthetically modified estrogen receptor (ERT2). 
Thus, this cre fusion protein can only be translocated to the nucleus and mediate 
recombination in the presence of tamoxifen. Cells with successful recombination will 












Hypothesis 1: Two separate sensory organs form from one Lfng(+) sensory patch by 
movement of non-sensory epithelial cells into the sensory patch and dividing it into 
two. This would lead to lacZ expression in the sensory organs only and not in non-
sensory cells in between the sensory organs. 
Alternative Hypothesis: Lfng expression is down-regulated within the Lfng(+) 
sensory patch to give rise to two separate sensory organs. Thus, lacZ expression 






                                            Glossary 
Cell-autonomous  
Regulation of cellular changes within the same cell 
Cochleo-vestibular ganglion (CVG) 
The VIII cranial nerve; Population of neurons comprised of auditory and vestibular 
ganglia 
High Mobility Growth domain (HMG) 
DNA binding domain of Sox proteins 
Ligand 
In this study the term ligand is used for cell-surface proteins, which bind to and 
interact with a cell-surface receptor protein in adjacent cells 
Neuronal fate  
Neuroblasts that are both Ngn1 and Neurod1 positive, which delaminate from the 
otic epithelium and form neurons of the cochleo-vestibular ganglion (CVG)  
Neural-sensory competent domain (NSD) 
An area located in the antero-ventral region of the otic cup or otocyst; Fate-mapping 
data indicate that cells in this region can give rise to both neuroblasts and sensory 
cells 
Neurosphere 
Free-floating cluster of neural stem cells in vitro 
Non-cell-autonomous  







Molecule that is a building block of RNA or DNA 
Oligo 
Oligonucleotide; Part of a short sequence of RNA or DNA nucleotides 
Plasmid 
A circular piece of double-stranded DNA that will replicate episomally in bacteria 
Pluripotency 
Ability of stem cells to develop into many different cell types 
Sensory fate  
Sensory progenitors that develop into either hair cells or supporting cells 
Subcloning 
A term used to describe cutting and pasting fragments of DNA using restriction 
enzymes 
Transcript 
Messenger RNA that will allow translation into a protein 
Transcription factor 
A protein that activates transcription of a gene by binding directly or in a complex 












                                                        Table of Genes 
Delta1, Serrate1 (Ser1), 
Serrate2 (Ser2) 
ligands for Notch receptors 
Hes5.1 basic-Helix-Loop-Helix (bHLH)   transcription 
factor of the Hairy and Enhancer-of-Split family 
activated by Notch signaling pathway; negative 
regulator of pro-neural bHLH genes 
Lunatic fringe (Lfng) extracellular modulator of Notch signaling  
Neurod1 pro-neural bHLH transcription factor activated by 
Ngn1 
Neurogenin 1 (Ngn1) pro-neural bHLH  transcription factor 
Notch1 trans-membrane receptor 
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